[{"path":"/LICENSE.html","id":null,"dir":"","previous_headings":"","what":"MIT License","title":"MIT License","text":"Copyright (c) 2023 ddir authors Permission hereby granted, free charge, person obtaining copy software associated documentation files (“Software”), deal Software without restriction, including without limitation rights use, copy, modify, merge, publish, distribute, sublicense, /sell copies Software, permit persons Software furnished , subject following conditions: copyright notice permission notice shall included copies substantial portions Software. SOFTWARE PROVIDED “”, WITHOUT WARRANTY KIND, EXPRESS IMPLIED, INCLUDING LIMITED WARRANTIES MERCHANTABILITY, FITNESS PARTICULAR PURPOSE NONINFRINGEMENT. EVENT SHALL AUTHORS COPYRIGHT HOLDERS LIABLE CLAIM, DAMAGES LIABILITY, WHETHER ACTION CONTRACT, TORT OTHERWISE, ARISING , CONNECTION SOFTWARE USE DEALINGS SOFTWARE.","code":""},{"path":"/authors.html","id":null,"dir":"","previous_headings":"","what":"Authors","title":"Authors and Citation","text":"Rainer Strotmann. Maintainer.","code":""},{"path":"/authors.html","id":"citation","dir":"","previous_headings":"","what":"Citation","title":"Authors and Citation","text":"Strotmann R (2024). ddir: Assessment clinical DDI risk drug compounds. R package version 0.12.1.","code":"@Manual{,   title = {ddir: Assessment of the clinical DDI risk for drug compounds},   author = {Rainer Strotmann},   year = {2024},   note = {R package version 0.12.1}, }"},{"path":"/index.html","id":"ddir","dir":"","previous_headings":"","what":"Assessment of the clinical DDI risk for drug compounds","title":"Assessment of the clinical DDI risk for drug compounds","text":"package provides functions analysis clinical drug-drug interaction (DDI) risk per relevant FDA EMA guidelines.","code":""},{"path":"/index.html","id":"installation","dir":"","previous_headings":"","what":"Installation","title":"Assessment of the clinical DDI risk for drug compounds","text":"can install development version ddir using:","code":"devtools::install_github(\"rstrotmann/ddir\")"},{"path":"/index.html","id":"example","dir":"","previous_headings":"","what":"Example","title":"Assessment of the clinical DDI risk for drug compounds","text":"package provides sample data fictional drug, examplinib. following code calculates perpetrator DDI risk direct CYP inhibition (basic method) provides markdown-formatted output table: See also: kinetic_cyp_induction_risk_table(), mech_stat_cyp_risk_table(), basic_ugt_inhibition_risk_table(), transporter_inhibition_risk_table() Full documentation can found github.","code":"library(ddir)  p <- examplinib_compounds[[1]] property_table(p) basic_cyp_inhibition_risk_table(p, examplinib_cyp_inhibition_data)"},{"path":"/reference/basic_cyp_inhibition_risk.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"function evaluates clinical risk direct (reversible) CYP inhibition according basic model defined relevant regulatory guidelines.","code":""},{"path":"/reference/basic_cyp_inhibition_risk.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"","code":"basic_cyp_inhibition_risk(perp, cyp_inh)"},{"path":"/reference/basic_cyp_inhibition_risk.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"perp perpetrator object. cyp_inh CYP inhibition data data frame. following fields expected: 'name' name perpetrator compound. 'cyp' CYP enzyme (upper case) character. 'ki' \\(k_i\\) \\(\\mu M\\) numeric. 'source' Optional source information character.","code":""},{"path":"/reference/basic_cyp_inhibition_risk.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"data frame.","code":""},{"path":"/reference/basic_cyp_inhibition_risk.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"basic modeling direct (reversible) CYP enzyme inhibition, ratio relevant inhibitor concentration \\(K_i\\) respective CYP enzyme considered, .e., \\(R_1\\) hepatic enzymes \\(R_{1,gut}\\) intestinal enzymes (refer fig. 1  FDA guidance).","code":""},{"path":"/reference/basic_cyp_inhibition_risk.html","id":"liver","dir":"Reference","previous_headings":"","what":"Liver","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"$$R_1=1+\\frac{I_{max,ss,u}}{K_{,u}}$$","code":""},{"path":"/reference/basic_cyp_inhibition_risk.html","id":"gut-wall","dir":"Reference","previous_headings":"","what":"Gut wall","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"$$R_{1,gut}=1+\\frac{I_{gut}}{K_{,u}}$$ \\(R_1\\) values > 1.02, .e., maximal unbound perpetrator concentrations 50-fold \\(K_i\\) considered indicate clinical risk using method. Note section 5.3.3.1 EMA DDI guidance defines relevant ratio \\(R_1=\\frac{I_{max,ss,u}}{K_{,u}}\\) threshold 0.02. output, columns risk_hep risk_intest indicate whether regulatory threshold reached respecive enzyme. Refer documentation key_concentrations() function details calculation \\(I_{max,ss,u}\\) \\(I_{gut}\\).","code":""},{"path":[]},{"path":"/reference/basic_cyp_inhibition_risk.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic CYP inhibition risk — basic_cyp_inhibition_risk","text":"","code":"basic_cyp_inhibition_risk(examplinib_parent, examplinib_cyp_inhibition_data) #>       cyp   ki  kiu    r1 risk_hep r1gut risk_intest #> 1  CYP1A2   NA   NA    NA       NA    NA          NA #> 2  CYP2B6   NA   NA    NA       NA    NA          NA #> 3  CYP2C8 11.0 11.0 1.015    FALSE    NA          NA #> 4  CYP2C9 13.5 13.5 1.012    FALSE    NA          NA #> 5 CYP2C19 15.0 15.0 1.011    FALSE    NA          NA #> 6  CYP2D6   NA   NA    NA       NA    NA          NA #> 7  CYP3A4 12.5 12.5 1.013    FALSE 293.3        TRUE"},{"path":"/reference/basic_cyp_inhibition_risk.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic CYP inhibition risk evaluation for a list of perpetrator objects — basic_cyp_inhibition_risk.list","title":"Basic CYP inhibition risk evaluation for a list of perpetrator objects — basic_cyp_inhibition_risk.list","text":"Basic CYP inhibition risk evaluation list perpetrator objects","code":""},{"path":"/reference/basic_cyp_inhibition_risk.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic CYP inhibition risk evaluation for a list of perpetrator objects — basic_cyp_inhibition_risk.list","text":"","code":"# S3 method for list basic_cyp_inhibition_risk(perp, cyp_inh)"},{"path":"/reference/basic_cyp_inhibition_risk.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic CYP inhibition risk evaluation for a list of perpetrator objects — basic_cyp_inhibition_risk.list","text":"perp Perpetrator objects list. cyp_inh CYP inhibition data data frame.","code":""},{"path":"/reference/basic_cyp_inhibition_risk.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic CYP inhibition risk evaluation for a list of perpetrator objects — basic_cyp_inhibition_risk.list","text":"list data frames.","code":""},{"path":"/reference/basic_cyp_inhibition_risk.list.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic CYP inhibition risk evaluation for a list of perpetrator objects — basic_cyp_inhibition_risk.list","text":"","code":"basic_cyp_inhibition_risk(examplinib_compounds, examplinib_cyp_inhibition_data) #> $examplinib #>     param   ki  kiu    r1 risk_hep r1gut risk_intest #> 1  CYP1A2   NA   NA    NA       NA    NA          NA #> 2  CYP2B6   NA   NA    NA       NA    NA          NA #> 3  CYP2C8 11.0 11.0 1.015    FALSE    NA          NA #> 4  CYP2C9 13.5 13.5 1.012    FALSE    NA          NA #> 5 CYP2C19 15.0 15.0 1.011    FALSE    NA          NA #> 6  CYP2D6   NA   NA    NA       NA    NA          NA #> 7  CYP3A4 12.5 12.5 1.013    FALSE 293.3        TRUE #>  #> $M1 #>    param  ki kiu    r1 risk_hep r1gut risk_intest #> 1 CYP2C9 4.4 4.4 1.006    FALSE    NA          NA #>"},{"path":"/reference/basic_cyp_inhibition_risk.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic CYP inhibition risk evaluation for a perpetrator object — basic_cyp_inhibition_risk.perpetrator","title":"Basic CYP inhibition risk evaluation for a perpetrator object — basic_cyp_inhibition_risk.perpetrator","text":"Basic CYP inhibition risk evaluation perpetrator object","code":""},{"path":"/reference/basic_cyp_inhibition_risk.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic CYP inhibition risk evaluation for a perpetrator object — basic_cyp_inhibition_risk.perpetrator","text":"","code":"# S3 method for perpetrator basic_cyp_inhibition_risk(perp, cyp_inh)"},{"path":"/reference/basic_cyp_inhibition_risk.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic CYP inhibition risk evaluation for a perpetrator object — basic_cyp_inhibition_risk.perpetrator","text":"perp perpetrator object. cyp_inh CYP inhibiton data data frame.","code":""},{"path":"/reference/basic_cyp_inhibition_risk.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic CYP inhibition risk evaluation for a perpetrator object — basic_cyp_inhibition_risk.perpetrator","text":"data frame.","code":""},{"path":"/reference/basic_cyp_inhibition_risk.perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic CYP inhibition risk evaluation for a perpetrator object — basic_cyp_inhibition_risk.perpetrator","text":"","code":"basic_cyp_inhibition_risk(examplinib_parent, examplinib_cyp_inhibition_data) #>     param   ki  kiu    r1 risk_hep r1gut risk_intest #> 1  CYP1A2   NA   NA    NA       NA    NA          NA #> 2  CYP2B6   NA   NA    NA       NA    NA          NA #> 3  CYP2C8 11.0 11.0 1.015    FALSE    NA          NA #> 4  CYP2C9 13.5 13.5 1.012    FALSE    NA          NA #> 5 CYP2C19 15.0 15.0 1.011    FALSE    NA          NA #> 6  CYP2D6   NA   NA    NA       NA    NA          NA #> 7  CYP3A4 12.5 12.5 1.013    FALSE 293.3        TRUE"},{"path":"/reference/basic_cyp_inhibition_risk_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic CYP inhibition risk table — basic_cyp_inhibition_risk_table","title":"Basic CYP inhibition risk table — basic_cyp_inhibition_risk_table","text":"function generates markdown-formatted table direct (reversible) CYP inhibition risk assessment. See basic_cyp_inhibition_risk() details calculation risk.","code":""},{"path":"/reference/basic_cyp_inhibition_risk_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic CYP inhibition risk table — basic_cyp_inhibition_risk_table","text":"","code":"basic_cyp_inhibition_risk_table(perp, cyp_inh, na.rm = FALSE)"},{"path":"/reference/basic_cyp_inhibition_risk_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic CYP inhibition risk table — basic_cyp_inhibition_risk_table","text":"perp perpetrator object. cyp_inh CYP inhibition data data frame. na.rm Switch define whether rows lacking \\(K_i\\) data removed output (.e., ki == NA). Defaults FALSE.","code":""},{"path":"/reference/basic_cyp_inhibition_risk_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic CYP inhibition risk table — basic_cyp_inhibition_risk_table","text":"markdown-formatted table, empty string.","code":""},{"path":[]},{"path":"/reference/basic_cyp_inhibition_risk_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic CYP inhibition risk table — basic_cyp_inhibition_risk_table","text":"","code":"basic_cyp_inhibition_risk_table(examplinib_parent, examplinib_cyp_inhibition_data) #>  #>  #> Table: Risk for direct CYP inhibition by examplinib (basic model) #>  #> |CYP     | $K_{i}$ (µM)| $K_{i,u}$ (µM)|$R_1$ |risk (hepatic) |$R_{1,gut}$ |risk (intestinal) | #> |:-------|------------:|--------------:|:-----|:--------------|:-----------|:-----------------| #> |CYP1A2  |           NA|             NA|NA    |NA             |NA          |NA                | #> |CYP2B6  |           NA|             NA|NA    |NA             |NA          |NA                | #> |CYP2C8  |         11.0|           11.0|1.015 |FALSE          |NA          |NA                | #> |CYP2C9  |         13.5|           13.5|1.012 |FALSE          |NA          |NA                | #> |CYP2C19 |         15.0|           15.0|1.011 |FALSE          |NA          |NA                | #> |CYP2D6  |           NA|             NA|NA    |NA             |NA          |NA                | #> |CYP3A4  |         12.5|           12.5|1.013 |FALSE          |293.3       |TRUE              | basic_cyp_inhibition_risk_table(examplinib_parent, examplinib_cyp_inhibition_data, na.rm = TRUE) #>  #>  #> Table: Risk for direct CYP inhibition by examplinib (basic model) #>  #> |CYP     | $K_{i}$ (µM)| $K_{i,u}$ (µM)|$R_1$ |risk (hepatic) |$R_{1,gut}$ |risk (intestinal) | #> |:-------|------------:|--------------:|:-----|:--------------|:-----------|:-----------------| #> |CYP2C8  |         11.0|           11.0|1.015 |FALSE          |NA          |NA                | #> |CYP2C9  |         13.5|           13.5|1.012 |FALSE          |NA          |NA                | #> |CYP2C19 |         15.0|           15.0|1.011 |FALSE          |NA          |NA                | #> |CYP3A4  |         12.5|           12.5|1.013 |FALSE          |293.3       |TRUE              |"},{"path":"/reference/basic_cyp_inhibition_risk_table.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.list","title":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.list","text":"Table basic CYP inhibition risk","code":""},{"path":"/reference/basic_cyp_inhibition_risk_table.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.list","text":"","code":"# S3 method for list basic_cyp_inhibition_risk_table(perp, cyp_inh, na.rm = F)"},{"path":"/reference/basic_cyp_inhibition_risk_table.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.list","text":"perp list perpetrator objects. cyp_inh CYP inhibition data data frame. na.rm Remove rows lacking ki data (.e., ki == NA).","code":""},{"path":"/reference/basic_cyp_inhibition_risk_table.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.list","text":"Basic evaluation CYP inhibition risk markdown-formatted tables, empty string CYP inhibition data available.","code":""},{"path":"/reference/basic_cyp_inhibition_risk_table.list.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.list","text":"","code":"basic_cyp_inhibition_risk_table(examplinib_compounds, examplinib_cyp_inhibition_data) #>  #>  #> Table: Risk for direct CYP inhibition by examplinib (basic model) #>  #> |CYP     | $K_{i}$| $K_{i,u}$|$R_1$ |risk (hepatic) |$R_{1,gut}$ |risk (intestinal) | #> |:-------|-------:|---------:|:-----|:--------------|:-----------|:-----------------| #> |CYP1A2  |      NA|        NA|NA    |NA             |NA          |NA                | #> |CYP2B6  |      NA|        NA|NA    |NA             |NA          |NA                | #> |CYP2C8  |    11.0|      11.0|1.015 |FALSE          |NA          |NA                | #> |CYP2C9  |    13.5|      13.5|1.012 |FALSE          |NA          |NA                | #> |CYP2C19 |    15.0|      15.0|1.011 |FALSE          |NA          |NA                | #> |CYP2D6  |      NA|        NA|NA    |NA             |NA          |NA                | #> |CYP3A4  |    12.5|      12.5|1.013 |FALSE          |293.3       |TRUE              | #>  #>  #> Table: Risk for direct CYP inhibition by M1 (basic model) #>  #> |CYP    | $K_{i}$| $K_{i,u}$|$R_1$ |risk (hepatic) |$R_{1,gut}$ |risk (intestinal) | #> |:------|-------:|---------:|:-----|:--------------|:-----------|:-----------------| #> |CYP2C9 |     4.4|       4.4|1.006 |FALSE          |NA          |NA                |"},{"path":"/reference/basic_cyp_inhibition_risk_table.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.perpetrator","title":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.perpetrator","text":"Table basic CYP inhibition risk","code":""},{"path":"/reference/basic_cyp_inhibition_risk_table.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.perpetrator","text":"","code":"# S3 method for perpetrator basic_cyp_inhibition_risk_table(perp, cyp_inh, na.rm = F)"},{"path":"/reference/basic_cyp_inhibition_risk_table.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.perpetrator","text":"perp perpetrator object. cyp_inh CYP inhibition data data frame. na.rm Remove rows lacking ki data (.e., ki == NA).","code":""},{"path":"/reference/basic_cyp_inhibition_risk_table.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.perpetrator","text":"Basic evaluation CYP inhibition risk markdown-formatted table, empty string CYP inhibition data available.","code":""},{"path":"/reference/basic_cyp_inhibition_risk_table.perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of basic CYP inhibition risk — basic_cyp_inhibition_risk_table.perpetrator","text":"","code":"basic_cyp_inhibition_risk_table(examplinib_parent, examplinib_cyp_inhibition_data) #>  #>  #> Table: Risk for direct CYP inhibition by examplinib (basic model) #>  #> |CYP     | $K_{i}$| $K_{i,u}$|$R_1$ |risk (hepatic) |$R_{1,gut}$ |risk (intestinal) | #> |:-------|-------:|---------:|:-----|:--------------|:-----------|:-----------------| #> |CYP1A2  |      NA|        NA|NA    |NA             |NA          |NA                | #> |CYP2B6  |      NA|        NA|NA    |NA             |NA          |NA                | #> |CYP2C8  |    11.0|      11.0|1.015 |FALSE          |NA          |NA                | #> |CYP2C9  |    13.5|      13.5|1.012 |FALSE          |NA          |NA                | #> |CYP2C19 |    15.0|      15.0|1.011 |FALSE          |NA          |NA                | #> |CYP2D6  |      NA|        NA|NA    |NA             |NA          |NA                | #> |CYP3A4  |    12.5|      12.5|1.013 |FALSE          |293.3       |TRUE              |"},{"path":"/reference/basic_cyp_tdi_risk.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic modeling of the CYP time-dependent inhibition risk — basic_cyp_tdi_risk","title":"Basic modeling of the CYP time-dependent inhibition risk — basic_cyp_tdi_risk","text":"function calculates risk time-dependent inhibition CYP enzymes.","code":""},{"path":"/reference/basic_cyp_tdi_risk.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic modeling of the CYP time-dependent inhibition risk — basic_cyp_tdi_risk","text":"","code":"basic_cyp_tdi_risk(perp, tdi, cyp_kdeg = cyp_turnover)"},{"path":"/reference/basic_cyp_tdi_risk.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic modeling of the CYP time-dependent inhibition risk — basic_cyp_tdi_risk","text":"perp perpetrator object. tdi CYP TDI data data frame. following fields expected: 'name' perpetrator compound name character. 'cyp' CYP enzyme character. 'ki' \\(K_I\\) µM numeric. 'kinact' \\(k_{inact}\\) 1/h numeric. 'source' Optional source information character, cyp_kdeg CYP turnover data data frame. Defaults built-reference data, cyp_turnover.","code":""},{"path":"/reference/basic_cyp_tdi_risk.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic modeling of the CYP time-dependent inhibition risk — basic_cyp_tdi_risk","text":"data frame.","code":""},{"path":"/reference/basic_cyp_tdi_risk.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Basic modeling of the CYP time-dependent inhibition risk — basic_cyp_tdi_risk","text":"relevant metric \\(R_2\\) defined fig. 2 FDA guidance: $$R_2=\\frac {k_{obs} + k_{deg}}{k_{deg}}$$ $$k_{obs}=\\frac {50*k_{inact}*I_{max,u}}{K_{,u} + 50*I_{max,u}}$$ Values \\(R_2 > 1.25\\) suggest relevant TDI potential. CYP degradation rates, \\(k_{deg}\\) physiological constants derived scientific literature. package provides standard values \\(k_{deg}\\) cyp_turnover commonly used. present version, risk hepatic TDI CYP enzymes calculated.","code":""},{"path":[]},{"path":"/reference/basic_cyp_tdi_risk.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic modeling of the CYP time-dependent inhibition risk — basic_cyp_tdi_risk","text":"","code":"basic_cyp_tdi_risk(examplinib_parent, examplinib_cyp_tdi_data) #>      cyp   ki    fu kinact   kdeg    source       r2 risk #> 1 CYP3A4 0.17 0.023   0.04 0.0193 study 001 3.071556 TRUE"},{"path":"/reference/basic_cyp_tdi_risk_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic CYP time-dependent inhibition risk table — basic_cyp_tdi_risk_table","title":"Basic CYP time-dependent inhibition risk table — basic_cyp_tdi_risk_table","text":"Basic CYP time-dependent inhibition risk table","code":""},{"path":"/reference/basic_cyp_tdi_risk_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic CYP time-dependent inhibition risk table — basic_cyp_tdi_risk_table","text":"","code":"basic_cyp_tdi_risk_table(perp, tdi, cyp_kdeg = cyp_turnover, na.rm = TRUE)"},{"path":"/reference/basic_cyp_tdi_risk_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic CYP time-dependent inhibition risk table — basic_cyp_tdi_risk_table","text":"perp perpetrator object. tdi CYP TDI data data frame. See basic_cyp_tdi_risk() details. cyp_kdeg CYP turnover data data frame. Defaults built-reference data, cyp_turnover. na.rm Switch define whether rows lacking \\(K_I\\) \\(k_{deg}\\) data removed output.","code":""},{"path":"/reference/basic_cyp_tdi_risk_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic CYP time-dependent inhibition risk table — basic_cyp_tdi_risk_table","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/basic_cyp_tdi_risk_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic CYP time-dependent inhibition risk table — basic_cyp_tdi_risk_table","text":"","code":"basic_cyp_tdi_risk_table(examplinib_parent, examplinib_cyp_tdi_data) #>  #>  #> Table: Risk for CYP TDI by examplinib (basic model) #>  #> |CYP    | $K_{I} (µM)$| $f_u$| $k_{inact}$ (1/h)| $k_{deg}$ (1/h)|source    | $R_2$|risk | #> |:------|------------:|-----:|-----------------:|---------------:|:---------|-----:|:----| #> |CYP3A4 |         0.17|  0.02|              0.04|            0.02|study 001 |  3.07|TRUE |"},{"path":"/reference/basic_ugt_inhibition_risk.html","id":null,"dir":"Reference","previous_headings":"","what":"UGT inhibition risk — basic_ugt_inhibition_risk","title":"UGT inhibition risk — basic_ugt_inhibition_risk","text":"function evaluates clinical risk reversible inhibition UGT enzymes according relevant FDA EMA guidelines.","code":""},{"path":"/reference/basic_ugt_inhibition_risk.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"UGT inhibition risk — basic_ugt_inhibition_risk","text":"","code":"basic_ugt_inhibition_risk(perp, ugt_inh)"},{"path":"/reference/basic_ugt_inhibition_risk.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"UGT inhibition risk — basic_ugt_inhibition_risk","text":"perp perpetrator object. ugt_inh UGT inhibition data data frame, following fields expected: 'name' name perpetrator compound. 'ugt' UGT enzyme (upper case) character. 'ic50' \\(IC_{50}\\) \\(\\mu M\\) numeric. 'source' Optional source information character.","code":""},{"path":"/reference/basic_ugt_inhibition_risk.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"UGT inhibition risk — basic_ugt_inhibition_risk","text":"markdown-formatted table.","code":""},{"path":"/reference/basic_ugt_inhibition_risk.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"UGT inhibition risk — basic_ugt_inhibition_risk","text":"function assumes UGT inhibition data provided \\(IC_{50}\\). According Cheng, Prusoff 1973), \\(K_i\\) can assumed \\(IC_{50}/2\\) experimental conditions commonly used vitro ihibition studies substrate concentrations close \\(K_M\\). relevant metric basic modeling UGT inhibition risk \\(R_1=I_{max,ss,u}/K_{,u}\\) (refer fig. 1  FDA guidance). \\(R_1>1.02\\) considered indicate potential UGT inhibition risk. Refer documentation key_concentrations() function details calculation \\(I_{max,ss,u}\\).","code":""},{"path":[]},{"path":"/reference/basic_ugt_inhibition_risk.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"UGT inhibition risk — basic_ugt_inhibition_risk","text":"","code":"basic_ugt_inhibition_risk(examplinib_parent, examplinib_ugt_inhibition_data) #>       ugt  kiu       r1 risk #> 1  UGT1A1 7.50 1.021976 TRUE #> 2  UGT1A3 7.50 1.021976 TRUE #> 3  UGT1A4 7.50 1.021976 TRUE #> 4  UGT1A6 7.50 1.021976 TRUE #> 5  UGT1A9 1.90 1.086747 TRUE #> 6  UGT2B7 7.50 1.021976 TRUE #> 7 UGT2B15 7.50 1.021976 TRUE #> 8 UGT2B17 3.05 1.054039 TRUE"},{"path":"/reference/basic_ugt_inhibition_risk_table.html","id":null,"dir":"Reference","previous_headings":"","what":"UGT inhibition risk table — basic_ugt_inhibition_risk_table","title":"UGT inhibition risk table — basic_ugt_inhibition_risk_table","text":"function generates markdown-formatted table reversible UGT inhibition risk assessment. See basic_ugt_inhibition_risk() details calculation risk.","code":""},{"path":"/reference/basic_ugt_inhibition_risk_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"UGT inhibition risk table — basic_ugt_inhibition_risk_table","text":"","code":"basic_ugt_inhibition_risk_table(perp, ugt_inh, na.rm = F)"},{"path":"/reference/basic_ugt_inhibition_risk_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"UGT inhibition risk table — basic_ugt_inhibition_risk_table","text":"perp perpetrator object. ugt_inh UGT inhibition data data frame, 'value' representing respective \\(IC_{50}\\). na.rm Boolean define whether rows lacking \\(K_i\\) data removed output (.e., ki == NA).","code":""},{"path":"/reference/basic_ugt_inhibition_risk_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"UGT inhibition risk table — basic_ugt_inhibition_risk_table","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/basic_ugt_inhibition_risk_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"UGT inhibition risk table — basic_ugt_inhibition_risk_table","text":"","code":"basic_ugt_inhibition_risk_table(examplinib_parent, examplinib_ugt_inhibition_data) #>  #>  #> Table: Risk for UGT inhibition by examplinib (basic model) #>  #> |UGT     | $K_{i,u}$| $R_1$|risk | #> |:-------|---------:|-----:|:----| #> |UGT1A1  |      7.50| 1.022|TRUE | #> |UGT1A3  |      7.50| 1.022|TRUE | #> |UGT1A4  |      7.50| 1.022|TRUE | #> |UGT1A6  |      7.50| 1.022|TRUE | #> |UGT1A9  |      1.90| 1.087|TRUE | #> |UGT2B7  |      7.50| 1.022|TRUE | #> |UGT2B15 |      7.50| 1.022|TRUE | #> |UGT2B17 |      3.05| 1.054|TRUE |"},{"path":"/reference/compound_names_string.html","id":null,"dir":"Reference","previous_headings":"","what":"Compound names as single string — compound_names_string","title":"Compound names as single string — compound_names_string","text":"function returns single string names perpetrator compounds listed nicely.","code":""},{"path":"/reference/compound_names_string.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Compound names as single string — compound_names_string","text":"","code":"compound_names_string(compounds)"},{"path":"/reference/compound_names_string.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Compound names as single string — compound_names_string","text":"compounds list perpetrator objects","code":""},{"path":"/reference/compound_names_string.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Compound names as single string — compound_names_string","text":"character string.","code":""},{"path":"/reference/compound_names_string.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Compound names as single string — compound_names_string","text":"","code":"compound_names_string(examplinib_compounds) #> [1] \"examplinib and M1\""},{"path":"/reference/conc_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of key perpetrator concentrations — conc_table","title":"Table of key perpetrator concentrations — conc_table","text":"function generates markdown-formatted table key perpetrator concentrations used assessment DDI perpetrator potential. See key_concentrations() details calculation.","code":""},{"path":"/reference/conc_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of key perpetrator concentrations — conc_table","text":"","code":"conc_table(perp)"},{"path":"/reference/conc_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of key perpetrator concentrations — conc_table","text":"perp perpetrator object list perpetrator objects.","code":""},{"path":"/reference/conc_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of key perpetrator concentrations — conc_table","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/conc_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of key perpetrator concentrations — conc_table","text":"","code":"conc_table(examplinib_parent) #>  #>  #> Table: Key perpetrator concentrations for examplinib #>  #> |parameter              |value (ng/ml) |value (uM) | #> |:----------------------|:-------------|:----------| #> |$I_{gut}$              |1800000.0     |3654.080   | #> |$I_{max,ss,u}$         |81.2          |0.165      | #> |$I_{max,inlet,u}$      |95.0          |0.193      | #> |$I_{max,intestinal,u}$ |74.6          |0.151      | conc_table(examplinib_compounds) #> $examplinib #>  #>  #> Table: Key perpetrator concentrations for examplinib #>  #> |parameter              |value (ng/ml) |value (uM) | #> |:----------------------|:-------------|:----------| #> |$I_{gut}$              |1800000.0     |3654.080   | #> |$I_{max,ss,u}$         |81.2          |0.165      | #> |$I_{max,inlet,u}$      |95.0          |0.193      | #> |$I_{max,intestinal,u}$ |74.6          |0.151      | #>  #> $M1 #>  #>  #> Table: Key perpetrator concentrations for M1 #>  #> |parameter              |value (ng/ml) |value (uM) | #> |:----------------------|:-------------|:----------| #> |$I_{gut}$              |0.0           |0.0000     | #> |$I_{max,ss,u}$         |12.5          |0.0246     | #> |$I_{max,inlet,u}$      |12.5          |0.0246     | #> |$I_{max,intestinal,u}$ |12.5          |0.0246     | #>"},{"path":"/reference/conc_table.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Key perpetrator concentrations — conc_table.list","title":"Key perpetrator concentrations — conc_table.list","text":"function generates list markdown-formatted tables key concentrations used assessment DDI perpetrator potential. See key_concentrations() details calculation concentrations.","code":""},{"path":"/reference/conc_table.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Key perpetrator concentrations — conc_table.list","text":"","code":"# S3 method for list conc_table(perp)"},{"path":"/reference/conc_table.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Key perpetrator concentrations — conc_table.list","text":"perp list perpetrator objects.","code":""},{"path":"/reference/conc_table.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Key perpetrator concentrations — conc_table.list","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/conc_table.list.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Key perpetrator concentrations — conc_table.list","text":"","code":"conc_table(examplinib_compounds) #> $examplinib #>  #>  #> Table: Key perpetrator concentrations for examplinib #>  #> |parameter              |value (ng/ml) |value (uM) | #> |:----------------------|:-------------|:----------| #> |$I_{gut}$              |1800000.0     |3654.080   | #> |$I_{max,ss,u}$         |81.2          |0.165      | #> |$I_{max,inlet,u}$      |95.0          |0.193      | #> |$I_{max,intestinal,u}$ |74.6          |0.151      | #>  #> $M1 #>  #>  #> Table: Key perpetrator concentrations for M1 #>  #> |parameter              |value (ng/ml) |value (uM) | #> |:----------------------|:-------------|:----------| #> |$I_{gut}$              |0.0           |0.0000     | #> |$I_{max,ss,u}$         |12.5          |0.0246     | #> |$I_{max,inlet,u}$      |12.5          |0.0246     | #> |$I_{max,intestinal,u}$ |12.5          |0.0246     | #>"},{"path":"/reference/conc_table.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Key perpetrator concentrations — conc_table.perpetrator","title":"Key perpetrator concentrations — conc_table.perpetrator","text":"function generates markdown-formatted table key perpetrator concentrations used assessment DDI perpetrator potential. See key_concentrations() details calculation.","code":""},{"path":"/reference/conc_table.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Key perpetrator concentrations — conc_table.perpetrator","text":"","code":"# S3 method for perpetrator conc_table(perp)"},{"path":"/reference/conc_table.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Key perpetrator concentrations — conc_table.perpetrator","text":"perp perpetrator object.","code":""},{"path":"/reference/conc_table.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Key perpetrator concentrations — conc_table.perpetrator","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/conc_table.perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Key perpetrator concentrations — conc_table.perpetrator","text":"","code":"conc_table(examplinib_parent) #>  #>  #> Table: Key perpetrator concentrations for examplinib #>  #> |parameter              |value (ng/ml) |value (uM) | #> |:----------------------|:-------------|:----------| #> |$I_{gut}$              |1800000.0     |3654.080   | #> |$I_{max,ss,u}$         |81.2          |0.165      | #> |$I_{max,inlet,u}$      |95.0          |0.193      | #> |$I_{max,intestinal,u}$ |74.6          |0.151      |"},{"path":"/reference/cyp_reference_substrates.html","id":null,"dir":"Reference","previous_headings":"","what":"CYP reference substrate data — cyp_reference_substrates","title":"CYP reference substrate data — cyp_reference_substrates","text":"CYP reference substrates commonly used mechanistic static assessment CYP DDI perpetrator potential drugs.","code":""},{"path":"/reference/cyp_reference_substrates.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"CYP reference substrate data — cyp_reference_substrates","text":"","code":"cyp_reference_substrates"},{"path":"/reference/cyp_reference_substrates.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"CYP reference substrate data — cyp_reference_substrates","text":"object class tbl_df (inherits tbl, data.frame) 5 rows 5 columns.","code":""},{"path":"/reference/cyp_reference_substrates.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"CYP reference substrate data — cyp_reference_substrates","text":"FDA EMA guidelines.","code":""},{"path":"/reference/cyp_reference_substrates.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"CYP reference substrate data — cyp_reference_substrates","text":"CYP reference substrates currently implemented include:","code":"cyp   substrate fgut   fm fmcyp  CYP1A2  tizanidine 1.00 0.95  0.98  CYP2C8 repaglinide 1.00 1.00  0.61  CYP2C9  S-warfarin 1.00 1.00  0.91 CYP2C19  omeprazole 1.00 1.00  0.87  CYP3A4   midazolam 0.57 0.96  1.00"},{"path":[]},{"path":"/reference/cyp_turnover.html","id":null,"dir":"Reference","previous_headings":"","what":"CYP turnover rate constants — cyp_turnover","title":"CYP turnover rate constants — cyp_turnover","text":"Mean degradation constants 1/h hepatic intestinal CYP enzymes.","code":""},{"path":"/reference/cyp_turnover.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"CYP turnover rate constants — cyp_turnover","text":"","code":"cyp_turnover"},{"path":"/reference/cyp_turnover.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"CYP turnover rate constants — cyp_turnover","text":"data frame 3 columns","code":""},{"path":"/reference/cyp_turnover.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"CYP turnover rate constants — cyp_turnover","text":"data set taken various literature sources","code":""},{"path":"/reference/cyp_turnover.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"CYP turnover rate constants — cyp_turnover","text":"","code":"cyp kdeg_hepatic kdeg_intestinal  CYP1A1       0.0183              NA  CYP1A2       0.0183              NA  CYP2A6       0.0267              NA  CYP2B6       0.0217              NA  CYP2C8       0.0301              NA  CYP2C9       0.0067            0.03 CYP2C18       0.0267              NA CYP2C19       0.0267            0.03  CYP2D6       0.0099            0.03  CYP2E1       0.0176              NA  CYP2J2       0.0194            0.03  CYP3A4       0.0193            0.03  CYP3A5       0.0193            0.03  CYP3A7       0.0193              NA"},{"path":[]},{"path":"/reference/ddir-package.html","id":null,"dir":"Reference","previous_headings":"","what":"ddir: Assessment of the clinical DDI risk for drug compounds — ddir-package","title":"ddir: Assessment of the clinical DDI risk for drug compounds — ddir-package","text":"goal ddir facilitate analysis drug-drug interaction risk drug compounds per relevant FDA EMA guidelines.","code":""},{"path":"/reference/df_to_string.html","id":null,"dir":"Reference","previous_headings":"","what":"Render data frame to character. — df_to_string","title":"Render data frame to character. — df_to_string","text":"function renders data frame string object.","code":""},{"path":"/reference/df_to_string.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Render data frame to character. — df_to_string","text":"","code":"df_to_string(df, indent = \"\", n = NULL, colnames = TRUE)"},{"path":"/reference/df_to_string.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Render data frame to character. — df_to_string","text":"df datavframe. indent string defines left indentation rendered output. n number lines rendered. NULL (default), lines rendered. colnames Boolean value indicate whether column names included output.","code":""},{"path":"/reference/df_to_string.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Render data frame to character. — df_to_string","text":"data frame representation character.","code":""},{"path":"/reference/examplinib_compounds.html","id":null,"dir":"Reference","previous_headings":"","what":"Perpetrator compound data for examplinib and its metabolite — examplinib_compounds","title":"Perpetrator compound data for examplinib and its metabolite — examplinib_compounds","text":"list two: perpetrator objects: examplinib, fictional drug. M1, fictional metabolite examplinib.","code":""},{"path":"/reference/examplinib_compounds.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Perpetrator compound data for examplinib and its metabolite — examplinib_compounds","text":"","code":"examplinib_compounds"},{"path":"/reference/examplinib_compounds.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Perpetrator compound data for examplinib and its metabolite — examplinib_compounds","text":"object class list length 2.","code":""},{"path":"/reference/examplinib_compounds.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Perpetrator compound data for examplinib and its metabolite — examplinib_compounds","text":"Fictional data, made demo purposes.","code":""},{"path":"/reference/examplinib_compounds_string.html","id":null,"dir":"Reference","previous_headings":"","what":"Examplinib compound data as string — examplinib_compounds_string","title":"Examplinib compound data as string — examplinib_compounds_string","text":"character string containing data two perpetrator objects: examplinib, fictional drug. M1, fictional metabolite examplinib.","code":""},{"path":"/reference/examplinib_compounds_string.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Examplinib compound data as string — examplinib_compounds_string","text":"","code":"examplinib_compounds_string"},{"path":"/reference/examplinib_compounds_string.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Examplinib compound data as string — examplinib_compounds_string","text":"object class character length 1.","code":""},{"path":"/reference/examplinib_compounds_string.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Examplinib compound data as string — examplinib_compounds_string","text":"Fictional data, made demo purposes.","code":""},{"path":[]},{"path":"/reference/examplinib_cyp_induction_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Examplinib CYP induction data — examplinib_cyp_induction_data","title":"Examplinib CYP induction data — examplinib_cyp_induction_data","text":"Examplinib CYP induction data","code":""},{"path":"/reference/examplinib_cyp_induction_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Examplinib CYP induction data — examplinib_cyp_induction_data","text":"","code":"examplinib_cyp_induction_data"},{"path":"/reference/examplinib_cyp_induction_data.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Examplinib CYP induction data — examplinib_cyp_induction_data","text":"object class data.frame 14 rows 6 columns.","code":""},{"path":"/reference/examplinib_cyp_induction_data.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Examplinib CYP induction data — examplinib_cyp_induction_data","text":"Fictional data, made demo purposes.","code":""},{"path":"/reference/examplinib_cyp_induction_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Examplinib CYP induction data — examplinib_cyp_induction_data","text":"","code":"name     cyp  emax ec50 maxc    source examplinib  CYP1A2  1.00   NA    5 study 007 examplinib  CYP2B6  1.00   NA    5 study 007 examplinib  CYP2C8    NA   NA   NA examplinib  CYP2C9    NA   NA   NA examplinib CYP2C19    NA   NA   NA examplinib  CYP2D6    NA   NA   NA examplinib  CYP3A4  7.35 1.64    3 study 007         M1  CYP1A2  1.00   NA    5 study 007         M1  CYP2B6  6.98 1.86    5 study 007         M1  CYP2C8    NA   NA   NA         M1  CYP2C9    NA   NA   NA         M1 CYP2C19    NA   NA   NA         M1  CYP2D6    NA   NA   NA         M1  CYP3A4 22.70 1.10    5 study 007"},{"path":"/reference/examplinib_cyp_induction_string.html","id":null,"dir":"Reference","previous_headings":"","what":"Examplinib CYP induction data as string — examplinib_cyp_induction_string","title":"Examplinib CYP induction data as string — examplinib_cyp_induction_string","text":"character string containing CYP induction data examplinib M1.","code":""},{"path":"/reference/examplinib_cyp_induction_string.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Examplinib CYP induction data as string — examplinib_cyp_induction_string","text":"","code":"examplinib_cyp_induction_string"},{"path":"/reference/examplinib_cyp_induction_string.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Examplinib CYP induction data as string — examplinib_cyp_induction_string","text":"object class character length 1.","code":""},{"path":"/reference/examplinib_cyp_induction_string.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Examplinib CYP induction data as string — examplinib_cyp_induction_string","text":"Fictional data demo purposes.","code":""},{"path":[]},{"path":"/reference/examplinib_cyp_inhibition_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Examplinib CYP inhibition data — examplinib_cyp_inhibition_data","title":"Examplinib CYP inhibition data — examplinib_cyp_inhibition_data","text":"data frame typical input following functions: basic_cyp_inhibition_risk() basic_cyp_inhibition_risk_table mech_stat_cyp_risk() mech_stat_cyp_risk_table()","code":""},{"path":"/reference/examplinib_cyp_inhibition_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Examplinib CYP inhibition data — examplinib_cyp_inhibition_data","text":"","code":"examplinib_cyp_inhibition_data"},{"path":[]},{"path":"/reference/examplinib_cyp_inhibition_data.html","id":"examplinib-cyp-inhibition-data","dir":"Reference","previous_headings":"","what":"examplinib_cyp_inhibition_data","title":"Examplinib CYP inhibition data — examplinib_cyp_inhibition_data","text":"data frame columns name, param, value source, : name name compound data recorded param contains respective CYP enzyme names. value contains Ki values respective CYP enzyme source provides information source respective value, often name DMPK study. entry optional.","code":""},{"path":"/reference/examplinib_cyp_inhibition_data.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Examplinib CYP inhibition data — examplinib_cyp_inhibition_data","text":"Fictional data, made demo purposes.","code":""},{"path":"/reference/examplinib_cyp_inhibition_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Examplinib CYP inhibition data — examplinib_cyp_inhibition_data","text":"CYP inhibition data can contain ki data multiple compounds.","code":"name   param      value    source         M1    name         M1         M1  CYP2C9        4.4 study 002 examplinib    name examplinib examplinib  CYP1A2         NA examplinib  CYP2B6         NA examplinib  CYP2C8         11 study 001 examplinib  CYP2C9       13.5 study 001 examplinib CYP2C19         15 study 001 examplinib  CYP2D6         NA examplinib  CYP3A4       12.5 study 001"},{"path":"/reference/examplinib_cyp_inhibition_string.html","id":null,"dir":"Reference","previous_headings":"","what":"Examplinib CYP inhibitor data as string — examplinib_cyp_inhibition_string","title":"Examplinib CYP inhibitor data as string — examplinib_cyp_inhibition_string","text":"character string containing CYP inhibition data examplinib M1.","code":""},{"path":"/reference/examplinib_cyp_inhibition_string.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Examplinib CYP inhibitor data as string — examplinib_cyp_inhibition_string","text":"","code":"examplinib_cyp_inhibition_string"},{"path":"/reference/examplinib_cyp_inhibition_string.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Examplinib CYP inhibitor data as string — examplinib_cyp_inhibition_string","text":"object class character length 1.","code":""},{"path":"/reference/examplinib_cyp_inhibition_string.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Examplinib CYP inhibitor data as string — examplinib_cyp_inhibition_string","text":"Fictional data demo purposes.","code":""},{"path":[]},{"path":"/reference/examplinib_cyp_tdi_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Examplinib CYP TDI data — examplinib_cyp_tdi_data","title":"Examplinib CYP TDI data — examplinib_cyp_tdi_data","text":"Examplinib CYP TDI data","code":""},{"path":"/reference/examplinib_cyp_tdi_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Examplinib CYP TDI data — examplinib_cyp_tdi_data","text":"","code":"examplinib_cyp_tdi_data"},{"path":"/reference/examplinib_cyp_tdi_data.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Examplinib CYP TDI data — examplinib_cyp_tdi_data","text":"object class data.frame 1 rows 5 columns.","code":""},{"path":"/reference/examplinib_cyp_tdi_data.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Examplinib CYP TDI data — examplinib_cyp_tdi_data","text":"Fictional data, made demo purposes.","code":""},{"path":"/reference/examplinib_cyp_tdi_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Examplinib CYP TDI data — examplinib_cyp_tdi_data","text":"","code":"name    cyp   ki kinact    source examplinib CYP3A4 30.7   0.04 study 001"},{"path":"/reference/examplinib_cyp_tdi_string.html","id":null,"dir":"Reference","previous_headings":"","what":"Examplinib CYP TDI data as string — examplinib_cyp_tdi_string","title":"Examplinib CYP TDI data as string — examplinib_cyp_tdi_string","text":"character string containing CYP TDI data examplinib.","code":""},{"path":"/reference/examplinib_cyp_tdi_string.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Examplinib CYP TDI data as string — examplinib_cyp_tdi_string","text":"","code":"examplinib_cyp_tdi_string"},{"path":"/reference/examplinib_cyp_tdi_string.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Examplinib CYP TDI data as string — examplinib_cyp_tdi_string","text":"object class character length 1.","code":""},{"path":"/reference/examplinib_cyp_tdi_string.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Examplinib CYP TDI data as string — examplinib_cyp_tdi_string","text":"Fictional data demo purposes.","code":""},{"path":[]},{"path":"/reference/examplinib_metabolite.html","id":null,"dir":"Reference","previous_headings":"","what":"Perpetrator compound data for examplinib — examplinib_metabolite","title":"Perpetrator compound data for examplinib — examplinib_metabolite","text":"Perpetrator compound data examplinib","code":""},{"path":"/reference/examplinib_metabolite.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Perpetrator compound data for examplinib — examplinib_metabolite","text":"","code":"examplinib_metabolite"},{"path":"/reference/examplinib_metabolite.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Perpetrator compound data for examplinib — examplinib_metabolite","text":"object class perpetrator (inherits data.frame) 12 rows 3 columns.","code":""},{"path":"/reference/examplinib_metabolite.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Perpetrator compound data for examplinib — examplinib_metabolite","text":"Fictional data, made demo purposes.","code":""},{"path":"/reference/examplinib_metabolite.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Perpetrator compound data for examplinib — examplinib_metabolite","text":"","code":"param  value    source name             name     M1 oral             oral  FALSE mw                 mw 506.56 dose             dose     NA imaxss         imaxss   1038 study 001 fu                 fu  0.012 study 002 fumic           fumic      1   default rb                 rb      1 study 002 fa                 fa     NA fg                 fg     NA ka                 ka     NA solubility solubility    Inf   default"},{"path":"/reference/examplinib_parent.html","id":null,"dir":"Reference","previous_headings":"","what":"Perpetrator compound data for examplinib — examplinib_parent","title":"Perpetrator compound data for examplinib — examplinib_parent","text":"Perpetrator compound data examplinib","code":""},{"path":"/reference/examplinib_parent.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Perpetrator compound data for examplinib — examplinib_parent","text":"","code":"examplinib_parent"},{"path":"/reference/examplinib_parent.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Perpetrator compound data for examplinib — examplinib_parent","text":"object class perpetrator (inherits data.frame) 12 rows 3 columns.","code":""},{"path":"/reference/examplinib_parent.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Perpetrator compound data for examplinib — examplinib_parent","text":"Fictional data, made demo purposes.","code":""},{"path":"/reference/examplinib_parent.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Perpetrator compound data for examplinib — examplinib_parent","text":"","code":"param      value        source name             name examplinib oral             oral       TRUE mw                 mw      492.6 dose             dose        450 clinical dose imaxss         imaxss       3530     study 001 fu                 fu      0.023     study 002 fumic           fumic          1       default rb                 rb          1     study 003 fa                 fa       0.81     study 003 fg                 fg          1       default ka                 ka    0.00267       unknown solubility solubility        Inf       default"},{"path":"/reference/examplinib_transporter_inhibition_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Examplinib transporter inhibition data — examplinib_transporter_inhibition_data","title":"Examplinib transporter inhibition data — examplinib_transporter_inhibition_data","text":"Examplinib transporter inhibition data","code":""},{"path":"/reference/examplinib_transporter_inhibition_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Examplinib transporter inhibition data — examplinib_transporter_inhibition_data","text":"","code":"examplinib_transporter_inhibition_data"},{"path":"/reference/examplinib_transporter_inhibition_data.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Examplinib transporter inhibition data — examplinib_transporter_inhibition_data","text":"object class data.frame 11 rows 4 columns.","code":""},{"path":"/reference/examplinib_transporter_inhibition_data.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Examplinib transporter inhibition data — examplinib_transporter_inhibition_data","text":"Fictional data, made demo purposes.","code":""},{"path":"/reference/examplinib_transporter_inhibition_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Examplinib transporter inhibition data — examplinib_transporter_inhibition_data","text":"","code":"name   param      value    source examplinib    name examplinib examplinib     Pgp       0.41 study 005 examplinib    BCRP        1.9 study 005 examplinib    OCT1        2.3 study 006 examplinib OATP1B1        177 study 006 examplinib OATP1B3         35 study 006 examplinib    OAT1        271 examplinib    OAT3        300 examplinib    BSEP       12.8 examplinib    OCT2         67 study 006 examplinib   MATE1        3.6 study 006 examplinib  MATE2k        1.1 study 006"},{"path":"/reference/examplinib_ugt_inhibition_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Examplinib UGT inhibition data — examplinib_ugt_inhibition_data","title":"Examplinib UGT inhibition data — examplinib_ugt_inhibition_data","text":"Examplinib UGT inhibition data","code":""},{"path":"/reference/examplinib_ugt_inhibition_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Examplinib UGT inhibition data — examplinib_ugt_inhibition_data","text":"","code":"examplinib_ugt_inhibition_data"},{"path":"/reference/examplinib_ugt_inhibition_data.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Examplinib UGT inhibition data — examplinib_ugt_inhibition_data","text":"data frame columns 'name', 'param', 'value' 'source'","code":""},{"path":"/reference/examplinib_ugt_inhibition_data.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Examplinib UGT inhibition data — examplinib_ugt_inhibition_data","text":"Fictional data, made demo purposes.","code":""},{"path":"/reference/examplinib_ugt_inhibition_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Examplinib UGT inhibition data — examplinib_ugt_inhibition_data","text":"","code":"name   param      value    source         M1    name         M1         M1  UGT1A1        1.1 study 009         M1  UGT1A3        5.8 study 009         M1  UGT1A4        6.2 study 009         M1  UGT1A6         15 study 009         M1  UGT1A9        3.6 study 009         M1  UGT2B7         15 study 009         M1 UGT2B15        9.6 study 009         M1 UGT2B17        2.2 study 009 examplinib    name examplinib examplinib  UGT1A1         15 study 009 examplinib  UGT1A3         15 study 009 examplinib  UGT1A4         15 study 009 examplinib  UGT1A6         15 study 009 examplinib  UGT1A9        3.8 study 009 examplinib  UGT2B7         15 study 009 examplinib UGT2B15         15 study 009 examplinib UGT2B17        6.1 study 009"},{"path":"/reference/hepatic_cyp_turnover.html","id":null,"dir":"Reference","previous_headings":"","what":"Hepatic CYP turnover data based on various publications — hepatic_cyp_turnover","title":"Hepatic CYP turnover data based on various publications — hepatic_cyp_turnover","text":"Please use cyp_turnover instead.","code":""},{"path":"/reference/hepatic_cyp_turnover.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Hepatic CYP turnover data based on various publications — hepatic_cyp_turnover","text":"","code":"hepatic_cyp_turnover"},{"path":"/reference/hepatic_cyp_turnover.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Hepatic CYP turnover data based on various publications — hepatic_cyp_turnover","text":"data frame 6 columns: cyp: CYP enzymne method: experimental method used () mean_hl: mean CYP degradation half-life measured, in_vivo: Study conducted vivo reference: source publication (PMID DOI) kdeg: CYP degradation constant, .e., \\(log(2)/mean half-life\\).","code":""},{"path":"/reference/hepatic_cyp_turnover.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Hepatic CYP turnover data based on various publications — hepatic_cyp_turnover","text":"data set taken : Yang J, Liao M, Shou M, Jamei M, Yeo KR, Tucker GT, Rostami-Hodjegan . Cytochrome p450 turnover: regulation synthesis degradation, methods determining rates, implications prediction drug interactions. Curr Drug Metab. 2008 Jun;9(5):384-94. doi: 10.2174/138920008784746382. PMID: 18537575.","code":""},{"path":"/reference/hepatic_cyp_turnover.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Hepatic CYP turnover data based on various publications — hepatic_cyp_turnover","text":"following experimental methods used original publication: vitro method 1: Radio-labeling enzyme (‘pulse-chase’ method) vitro method 2: Degradation enzyme cultured hepatocytes liver slices vivo method 1: Recovery enzyme activity enzyme induction vivo method 2: Recovery enzyme activity mechanism-based inhibition (MBI) vivo method 3: Pharmacokinetic modeling auto-induction first lines data frame:","code":"cyp            method mean_hl in_vivo                       reference   kdeg CYP1A2 In vitro Method 1      51   FALSE                   PMID: 2136526 0.0136 CYP1A2 In vitro Method 2      43   FALSE   DOI: 10.1007/3-540-29804-5_25 0.0161 CYP1A2 In vitro Method 2      36   FALSE                  PMID: 10997941 0.0193 CYP1A2  In vivo Method 1      39    TRUE DOI: 10.1016/j.clpt.2004.04.003 0.0178 CYP1A2  In vivo Method 3     105    TRUE    DOI: 10.1038/sj.clpt.6100431 0.0066 CYP2A6 In vitro Method 2     226   FALSE                  PMID: 10997941 0.0031"},{"path":"/reference/is_igut_solubility_limited.html","id":null,"dir":"Reference","previous_headings":"","what":"Test if Igut of a perpetrator is limited by its solubility — is_igut_solubility_limited","title":"Test if Igut of a perpetrator is limited by its solubility — is_igut_solubility_limited","text":"function tests whether solubility perpetrator compound limiting intestinal concentration.","code":""},{"path":"/reference/is_igut_solubility_limited.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Test if Igut of a perpetrator is limited by its solubility — is_igut_solubility_limited","text":"","code":"is_igut_solubility_limited(obj)"},{"path":"/reference/is_igut_solubility_limited.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Test if Igut of a perpetrator is limited by its solubility — is_igut_solubility_limited","text":"obj perpetrator object.","code":""},{"path":"/reference/is_igut_solubility_limited.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Test if Igut of a perpetrator is limited by its solubility — is_igut_solubility_limited","text":"Boolean value.","code":""},{"path":"/reference/is_igut_solubility_limited.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Test if Igut of a perpetrator is limited by its solubility — is_igut_solubility_limited","text":"'solubility' field Inf (default), compound solubility larger \\(I_{gut}\\), function returns FALSE. solubility lower theoretical \\(I_{gut}\\), .e., lower dose dissolved 250 ml, function returns TRUE. Note solubility expected mg/l.","code":""},{"path":[]},{"path":"/reference/is_igut_solubility_limited.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Test if Igut of a perpetrator is limited by its solubility — is_igut_solubility_limited","text":"","code":"is_igut_solubility_limited(examplinib_parent) #> [1] FALSE"},{"path":"/reference/key_concentrations.html","id":null,"dir":"Reference","previous_headings":"","what":"Key perpetrator concentrations — key_concentrations","title":"Key perpetrator concentrations — key_concentrations","text":"function calculates relevant perpetrator concentrations \\(\\mu M\\) (default) ng/ml DDI perpetrator compound.","code":""},{"path":"/reference/key_concentrations.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Key perpetrator concentrations — key_concentrations","text":"","code":"key_concentrations(obj, qh = 1.616, qent = 18/60, molar = TRUE)"},{"path":"/reference/key_concentrations.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Key perpetrator concentrations — key_concentrations","text":"obj perpetrator object. qh Hepatic blood flow l/min, defaults 1.616 l/min. qent Enteric blood flow l/min, defaults 0.3 l/min = 18 l/h. molar Switch select output molar concentrations.","code":""},{"path":"/reference/key_concentrations.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Key perpetrator concentrations — key_concentrations","text":"Key perpetrator concentrations uM (default) ng/ml named vector.","code":""},{"path":[]},{"path":"/reference/key_concentrations.html","id":"gut-concentration","dir":"Reference","previous_headings":"","what":"Gut concentration","title":"Key perpetrator concentrations — key_concentrations","text":"$$I_{gut} = \\frac{D} {250}$$ exceeds aqueous solubility drug, \\(I_{gut}\\) set solubility.","code":""},{"path":"/reference/key_concentrations.html","id":"unbound-systemic-concentration","dir":"Reference","previous_headings":"","what":"Unbound systemic concentration","title":"Key perpetrator concentrations — key_concentrations","text":"$$I_{max,ss,u}=I_{max,ss} * f_u$$","code":""},{"path":"/reference/key_concentrations.html","id":"unbound-hepatic-inlet-concentration","dir":"Reference","previous_headings":"","what":"Unbound hepatic inlet concentration","title":"Key perpetrator concentrations — key_concentrations","text":"orally administered (parent) compounds, hepatic inlet concentration systemic concentration plus portal term: $$portal\\ term = D*\\frac{F_a*F_g*k_a}{Q_h*R_B}*1000\\ ng/ml$$ \\(D\\) administered dose mg, \\(F_a\\) fraction absorbed oral administration, \\(F_g\\) fraction available gut metabolism, \\(k_a\\) absorption rate, \\(Q_h\\) hepatic blood flow \\(R_B\\) blood--plasma ratio. relevant hepatic inlet concentration (\\(I_{max,inlet,u}\\), also called \\(I_h\\) mechanistic static modeling equations) concentration sum maximal systemic plasma concentration portal contribution: $$I_{max,inlet,u}=(I_{max,ss} + portal\\ term) * f_u$$","code":""},{"path":"/reference/key_concentrations.html","id":"unbound-enteric-concentration","dir":"Reference","previous_headings":"","what":"Unbound enteric concentration","title":"Key perpetrator concentrations — key_concentrations","text":"orally administered (parent) compounds, villous concentration gut (\\(I_{enteric}\\), also called \\(I_g\\) mechanistic static modeling equations) calculated : $$I_{enteric,u} = D * \\frac{F_a*k_a}{Q_{ent}} *1000\\ ng/ml$$ \\(F_a\\) fraction absorbed oral administration, \\(k_a\\) absorption rate, \\(Q_{ent}\\) enteric villous blood flow \\(R_B\\) blood--plasma distribution ratio compound. Note per FDA guideline (refer FDA, 2020, Fig. 7, Rostami-Hodjegan Tucker, 2004) blood--plasma ratio plasma binding drug ignored.","code":""},{"path":[]},{"path":"/reference/key_concentrations.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Key perpetrator concentrations — key_concentrations","text":"","code":"key_concentrations(examplinib_parent) #>         igut      imaxssu   imaxinletu  imaxintestu  #> 3654.0803898    0.1648193    0.1929384    0.1514680  key_concentrations(examplinib_parent, molar = FALSE) #>         igut      imaxssu   imaxinletu  imaxintestu  #> 1.800000e+06 8.119000e+01 9.504145e+01 7.461315e+01  key_concentrations(examplinib_metabolite) #>        igut     imaxssu  imaxinletu imaxintestu  #>  0.00000000  0.02458939  0.02458939  0.02458939"},{"path":"/reference/kinetic_cyp_induction_risk.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk","text":"Basic kinetic CYP induction risk","code":""},{"path":"/reference/kinetic_cyp_induction_risk.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk","text":"","code":"kinetic_cyp_induction_risk(perp, cyp_ind, d = 1)"},{"path":"/reference/kinetic_cyp_induction_risk.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk","text":"perp perpetrator object. cyp_ind CYP induction data data frame. following fields expected: 'name' name perpetrator compound character. 'cyp' CYP enzyme (upper case) character. 'emax' \\(E_{max}\\), .e., maximum induction effect determined vitro numeric. 'ec50' \\(EC_{50}\\) µM numeric. 'maxc' maximal concentration µM tested vitro assay numeric. 'source' Optional source information character. d Scaling factor, defaults 1.","code":""},{"path":"/reference/kinetic_cyp_induction_risk.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk","text":"data frame.","code":""},{"path":"/reference/kinetic_cyp_induction_risk.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk","text":"Basic kinetic modeling CYP induction risk considers \\(R_3\\) (refer fig. 4 FDA guideline): $$R_3 = \\frac {1}{1+d* \\frac {E_{max}*10*I_{max,u}}{EC_{50} + 10*I_{max,u}}}$$ \\(d\\) scaling factor standard value 1. different value can used warranted prior experience experimental setup. \\(R_3 \\le 0.8\\) suggests relevant vivo induction potential.","code":""},{"path":"/reference/kinetic_cyp_induction_risk.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk","text":"","code":"kinetic_cyp_induction_risk(examplinib_parent, examplinib_cyp_induction_data) #>       cyp emax ec50 maxc    source        r3 risk #> 1  CYP1A2 1.00   NA    5 study 007        NA   NA #> 2  CYP2B6 1.00   NA    5 study 007        NA   NA #> 3  CYP2C8   NA   NA   NA                  NA   NA #> 4  CYP2C9   NA   NA   NA                  NA   NA #> 5 CYP2C19   NA   NA   NA                  NA   NA #> 6  CYP2D6   NA   NA   NA                  NA   NA #> 7  CYP3A4 7.35 1.64    3 study 007 0.2134856 TRUE"},{"path":"/reference/kinetic_cyp_induction_risk.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.list","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.list","text":"Basic kinetic CYP induction risk","code":""},{"path":"/reference/kinetic_cyp_induction_risk.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.list","text":"","code":"# S3 method for list kinetic_cyp_induction_risk(perp, cyp_ind)"},{"path":"/reference/kinetic_cyp_induction_risk.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.list","text":"perp list perpetrator objects. cyp_ind CYP induction data data frame.","code":""},{"path":"/reference/kinetic_cyp_induction_risk.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.list","text":"list data frames.","code":""},{"path":"/reference/kinetic_cyp_induction_risk.list.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.list","text":"","code":"kinetic_cyp_induction_risk(examplinib_compounds, examplinib_cyp_induction_data) #> $examplinib #>       cyp emax ec50 maxc    source        r3 risk #> 1  CYP1A2 1.00   NA    5 study 007        NA   NA #> 2  CYP2B6 1.00   NA    5 study 007        NA   NA #> 3  CYP2C8   NA   NA   NA                  NA   NA #> 4  CYP2C9   NA   NA   NA                  NA   NA #> 5 CYP2C19   NA   NA   NA                  NA   NA #> 6  CYP2D6   NA   NA   NA                  NA   NA #> 7  CYP3A4 7.35 1.64    3 study 007 0.2134856 TRUE #>  #> $M1 #>       cyp  emax ec50 maxc    source        r3 risk #> 1  CYP1A2  1.00   NA    5 study 007        NA   NA #> 2  CYP2B6  6.98 1.86    5 study 007 0.5509590 TRUE #> 3  CYP2C8    NA   NA   NA                  NA   NA #> 4  CYP2C9    NA   NA   NA                  NA   NA #> 5 CYP2C19    NA   NA   NA                  NA   NA #> 6  CYP2D6    NA   NA   NA                  NA   NA #> 7  CYP3A4 22.70 1.10    5 study 007 0.1942776 TRUE #>"},{"path":"/reference/kinetic_cyp_induction_risk.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.perpetrator","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.perpetrator","text":"Basic kinetic CYP induction risk","code":""},{"path":"/reference/kinetic_cyp_induction_risk.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.perpetrator","text":"","code":"# S3 method for perpetrator kinetic_cyp_induction_risk(perp, cyp_ind)"},{"path":"/reference/kinetic_cyp_induction_risk.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.perpetrator","text":"perp perpetrator object. cyp_ind CYP induction data data frame.","code":""},{"path":"/reference/kinetic_cyp_induction_risk.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.perpetrator","text":"data frame.","code":""},{"path":"/reference/kinetic_cyp_induction_risk.perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic kinetic CYP induction risk — kinetic_cyp_induction_risk.perpetrator","text":"","code":"kinetic_cyp_induction_risk(examplinib_parent, examplinib_cyp_induction_data) #>       cyp emax ec50 maxc    source        r3 risk #> 1  CYP1A2 1.00   NA    5 study 007        NA   NA #> 2  CYP2B6 1.00   NA    5 study 007        NA   NA #> 3  CYP2C8   NA   NA   NA                  NA   NA #> 4  CYP2C9   NA   NA   NA                  NA   NA #> 5 CYP2C19   NA   NA   NA                  NA   NA #> 6  CYP2D6   NA   NA   NA                  NA   NA #> 7  CYP3A4 7.35 1.64    3 study 007 0.2134856 TRUE"},{"path":"/reference/kinetic_cyp_induction_risk_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table","text":"Table basic kinetc CYP induction risk","code":""},{"path":"/reference/kinetic_cyp_induction_risk_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table","text":"","code":"kinetic_cyp_induction_risk_table(perp, cyp_ind, na.rm = F)"},{"path":"/reference/kinetic_cyp_induction_risk_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table","text":"perp perpetrator object. cyp_ind CYP induction data data frame. See kinetic_cyp_induction_risk() details. na.rm Remove rows lacking ki data (.e., ki == NA).","code":""},{"path":"/reference/kinetic_cyp_induction_risk_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/kinetic_cyp_induction_risk_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table","text":"","code":"kinetic_cyp_induction_risk_table(examplinib_parent, examplinib_cyp_induction_data) #>  #>  #> Table: Risk for CYP induction by examplinib (basic kinetic model) #>  #> |CYP     | $E_{max}$| $EC_{50}$ (µM)| $max c$ (µM)|source    |$R_3$ |risk | #> |:-------|---------:|--------------:|------------:|:---------|:-----|:----| #> |CYP1A2  |      1.00|             NA|            5|study 007 |NA    |NA   | #> |CYP2B6  |      1.00|             NA|            5|study 007 |NA    |NA   | #> |CYP2C8  |        NA|             NA|           NA|          |NA    |NA   | #> |CYP2C9  |        NA|             NA|           NA|          |NA    |NA   | #> |CYP2C19 |        NA|             NA|           NA|          |NA    |NA   | #> |CYP2D6  |        NA|             NA|           NA|          |NA    |NA   | #> |CYP3A4  |      7.35|           1.64|            3|study 007 |0.213 |TRUE |"},{"path":"/reference/kinetic_cyp_induction_risk_table.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table.list","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table.list","text":"Table basic kinetc CYP induction risk","code":""},{"path":"/reference/kinetic_cyp_induction_risk_table.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table.list","text":"","code":"# S3 method for list kinetic_cyp_induction_risk_table(perp, cyp_ind, na.rm = F)"},{"path":"/reference/kinetic_cyp_induction_risk_table.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table.list","text":"perp list perpetrator objects. cyp_ind CYP induction data data frame. na.rm Remove rows lacking ki data (.e., ki == NA).","code":""},{"path":"/reference/kinetic_cyp_induction_risk_table.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table.list","text":"markdown-formatted table.","code":""},{"path":"/reference/kinetic_cyp_induction_risk_table.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table.perpetrator","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table.perpetrator","text":"Table basic kinetc CYP induction risk","code":""},{"path":"/reference/kinetic_cyp_induction_risk_table.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table.perpetrator","text":"","code":"# S3 method for perpetrator kinetic_cyp_induction_risk_table(perp, cyp_ind, na.rm = F)"},{"path":"/reference/kinetic_cyp_induction_risk_table.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table.perpetrator","text":"perp perpetrator object. cyp_ind CYP induction data data frame. na.rm Remove rows lacking ki data (.e., ki == NA).","code":""},{"path":"/reference/kinetic_cyp_induction_risk_table.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table.perpetrator","text":"markdown-formatted table.","code":""},{"path":"/reference/kinetic_cyp_induction_risk_table.perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of the basic kinetc CYP induction risk — kinetic_cyp_induction_risk_table.perpetrator","text":"","code":"kinetic_cyp_induction_risk_table(examplinib_parent, examplinib_cyp_induction_data) #>  #>  #> Table: Risk for CYP induction by examplinib (basic kinetic model) #>  #> |CYP     | $E_{max}$| $EC_{50}$| $max c$|source    |$R_3$ |risk | #> |:-------|---------:|---------:|-------:|:---------|:-----|:----| #> |CYP1A2  |      1.00|        NA|       5|study 007 |NA    |NA   | #> |CYP2B6  |      1.00|        NA|       5|study 007 |NA    |NA   | #> |CYP2C8  |        NA|        NA|      NA|          |NA    |NA   | #> |CYP2C9  |        NA|        NA|      NA|          |NA    |NA   | #> |CYP2C19 |        NA|        NA|      NA|          |NA    |NA   | #> |CYP2D6  |        NA|        NA|      NA|          |NA    |NA   | #> |CYP3A4  |      7.35|      1.64|       3|study 007 |0.213 |TRUE |"},{"path":"/reference/make_perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Make a perpetrator object from compound data — make_perpetrator","title":"Make a perpetrator object from compound data — make_perpetrator","text":"function creates perpetrator object key compound data. Note 'source' field empty. want include source information, can either use new_perpetrator() takes input data may include source information, can create perpetrator object text input string using read_perpetrators().","code":""},{"path":"/reference/make_perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Make a perpetrator object from compound data — make_perpetrator","text":"","code":"make_perpetrator(   name,   dose,   imaxss,   mw,   type = \"parent\",   oral = TRUE,   fu = 1,   fumic = 1,   rb = 1,   fa = 1,   fg = 1,   ka = 0.1,   solubility = Inf )"},{"path":"/reference/make_perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Make a perpetrator object from compound data — make_perpetrator","text":"name compound name character. dose clinical dose mg. imaxss (total) steady-state Cmax ng/ml. mw molar weight g/mol. type compound type character. Must either 'parent' metabolite'. oral Oral administration Boolean. Defaults TRUE. fu fraction unbound numeric. Defaults 1. fumic fraction unbound microsomes. Defaults 1. rb blood--plasma concentration ratio. Defaults 1. fa fraction absorbed. Defaults 1. fg fraction escaping gut metabolism. Defaults 1. ka absorption rate constant /ml. Defaults 0.1 /ml. solubility aqueus solubility mg/l. Defaults Inf,","code":""},{"path":"/reference/make_perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Make a perpetrator object from compound data — make_perpetrator","text":"perpetrator object.","code":""},{"path":[]},{"path":"/reference/make_perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Make a perpetrator object from compound data — make_perpetrator","text":"","code":"make_perpetrator(\"test\", 100, 1000, 500) #> Deprecation warning: The input contains the field 'type'. This field was expected #> to have the values 'parent' or 'metabolite' to indicate whether the compound is #> subject to first-pass metabolism. This field has been deprecated. Please use instead #> 'oral' with the possible, values of 'TRUE' or 'FALSE'! #> For compatibility reasons, the field 'oral' bas been autogenerated and your input #> should still work. However, this function may be deleted in future releases. #> == DDI perpetrator object == #> name         test              #> oral         TRUE              #> mw           500               #> dose         100               #> imaxss       1000              #> fu           1                 #> fumic        1                 #> rb           1                 #> fa           1                 #> fg           1                 #> ka           0.1               #> solubility   Inf"},{"path":"/reference/mech_stat_cyp_risk.html","id":null,"dir":"Reference","previous_headings":"","what":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"CYP perpetration risk per mechanistic-static modeling","code":""},{"path":"/reference/mech_stat_cyp_risk.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"","code":"mech_stat_cyp_risk(   perp,   cyp_inh,   cyp_ind,   cyp_tdi = NULL,   d = 1,   include_induction = TRUE,   substr = cyp_reference_substrates,   kdeg = cyp_turnover )"},{"path":"/reference/mech_stat_cyp_risk.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"perp perpetrator object. cyp_inh CYP inhibition data data frame, see basic_cyp_inhibition_risk details. cyp_ind CYP induction data data frame. See kinetic_cyp_induction_risk details. cyp_tdi CYP TDI data data frame. See basic_cyp_tdi_risk details. d Induction scaling factor, defaults 1. include_induction Switch define whether induction effects included calculation (C-terms per FDA guideline) substr CYP probe substrates used data frame, defaults cyp_reference_substrates. data frame expected following fields: 'cyp' CYP enzyme (upper case) character. 'substrate' substrate name character. 'fgut' fraction drug escaping gut metabolism. 'fm' fraction drug undergoes hepatic metabolism. 'fmcyp' fraction metabolized respective CYP enzyme. kdeg CYP turnover data data frame. Defaults built-reference data, cyp_turnover","code":""},{"path":"/reference/mech_stat_cyp_risk.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"data frame.","code":""},{"path":"/reference/mech_stat_cyp_risk.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"approach, AUC ratios probe substrates calculated based known intestinal hepatic metabolism. direct (competitive) time-dependent inhibition considered. formula given FDA guideline (refer fig. 7 FDA, 2020) also includes intestinal hepatic enzyme induction terms (\\(C_g\\) \\(C_h\\), respectively). time, guideline states inhibition induction considered separately. $$AUCR = \\frac{1}{A_g*B_g*C_g* \\left(1-F_g \\right)+F_g} * \\frac{1}{A_h*B_h*C_h*f_m+\\left(1-f_m\\right)}$$ individual terms :","code":""},{"path":"/reference/mech_stat_cyp_risk.html","id":"reversible-inhibition","dir":"Reference","previous_headings":"","what":"Reversible inhibition","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"$$A_g = \\frac{1}{1+\\frac{I_g}{K_i}}$$ $$A_h = \\frac{1}{1+\\frac{I_h}{K_i}}$$","code":""},{"path":"/reference/mech_stat_cyp_risk.html","id":"time-dependent-inhibition","dir":"Reference","previous_headings":"","what":"Time-dependent inhibition","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"$$B_g = \\frac{k_{deg,g}}{k_{deg,g} + \\frac{I_g*k_{inact}}{I_g+K_I}}$$ $$B_h = \\frac{k_{deg,h}}{k_{deg,h} + \\frac{I_h*k_{inact}}{I_h+K_I}}$$","code":""},{"path":"/reference/mech_stat_cyp_risk.html","id":"induction","dir":"Reference","previous_headings":"","what":"Induction","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"$$C_g = 1 + \\frac{d*E_{max}*I_g}{I_g+EC_{50}}$$ $$C_h = 1 + \\frac{d*E_{max}*I_h}{I_h+EC_{50}}$$ hepatic inlet concentration \\(I_h=I_{max,inlet,u}\\) intestinal concentration \\(I_g=I_{enteric,u}\\), see key_concentrations(). \\(d\\) scaling factor CYP induction term standard value 1. different value can used warranted prior experience experimental setup.","code":""},{"path":[]},{"path":"/reference/mech_stat_cyp_risk.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"CYP perpetration risk as per mechanistic-static modeling — mech_stat_cyp_risk","text":"","code":"mech_stat_cyp_risk(examplinib_parent, examplinib_cyp_inhibition_data,   examplinib_cyp_induction_data) #>       cyp   substrate  kiu fgut   fm fmcyp        Ag        Ah Bg Bh      Cg #> 1  CYP1A2  tizanidine   NA 1.00 0.95  0.98 1.0000000 1.0000000  1  1 1.00000 #> 2  CYP2B6        <NA>   NA   NA   NA    NA 1.0000000 1.0000000  1  1 1.00000 #> 3  CYP2C8 repaglinide 11.0 1.00 1.00  0.61 0.9864172 0.9827625  1  1 1.00000 #> 4  CYP2C9  S-warfarin 13.5 1.00 1.00  0.91 0.9889046 0.9859096  1  1 1.00000 #> 5 CYP2C19  omeprazole 15.0 1.00 1.00  0.87 0.9900031 0.9873008  1  1 1.00000 #> 6  CYP2D6        <NA>   NA   NA   NA    NA 1.0000000 1.0000000  1  1 1.00000 #> 7  CYP3A4   midazolam 12.5 0.57 0.96  1.00 0.9880276 0.9847995  1  1 1.62144 #>         Ch      aucr  risk #> 1 1.000000 1.0000000 FALSE #> 2 1.000000        NA    NA #> 3 1.000000 1.0106266 FALSE #> 4 1.000000 1.0129888 FALSE #> 5 1.000000 1.0111717 FALSE #> 6 1.000000        NA    NA #> 7 1.773674 0.4626871  TRUE mech_stat_cyp_risk(examplinib_parent, examplinib_cyp_inhibition_data,   examplinib_cyp_induction_data, examplinib_cyp_tdi_data) #>       cyp   substrate  kiu fgut   fm fmcyp        Ag        Ah        Bg #> 1  CYP1A2  tizanidine   NA 1.00 0.95  0.98 1.0000000 1.0000000 1.0000000 #> 2  CYP2B6        <NA>   NA   NA   NA    NA 1.0000000 1.0000000 1.0000000 #> 3  CYP2C8 repaglinide 11.0 1.00 1.00  0.61 0.9864172 0.9827625 1.0000000 #> 4  CYP2C9  S-warfarin 13.5 1.00 1.00  0.91 0.9889046 0.9859096 1.0000000 #> 5 CYP2C19  omeprazole 15.0 1.00 1.00  0.87 0.9900031 0.9873008 1.0000000 #> 6  CYP2D6        <NA>   NA   NA   NA    NA 1.0000000 1.0000000 1.0000000 #> 7  CYP3A4   midazolam 12.5 0.57 0.96  1.00 0.9880276 0.9847995 0.6141621 #>          Bh      Cg       Ch     aucr  risk #> 1 1.0000000 1.00000 1.000000 1.000000 FALSE #> 2 1.0000000 1.00000 1.000000       NA    NA #> 3 1.0000000 1.00000 1.000000 1.010627 FALSE #> 4 1.0000000 1.00000 1.000000 1.012989 FALSE #> 5 1.0000000 1.00000 1.000000 1.011172 FALSE #> 6 1.0000000 1.00000 1.000000       NA    NA #> 7 0.4757909 1.62144 1.773674 1.201881 FALSE mech_stat_cyp_risk(examplinib_parent, examplinib_cyp_inhibition_data,   examplinib_cyp_induction_data, examplinib_cyp_tdi_data,   include_induction = FALSE) #>       cyp   substrate  kiu fgut   fm fmcyp        Ag        Ah        Bg #> 1  CYP1A2  tizanidine   NA 1.00 0.95  0.98 1.0000000 1.0000000 1.0000000 #> 2  CYP2B6        <NA>   NA   NA   NA    NA 1.0000000 1.0000000 1.0000000 #> 3  CYP2C8 repaglinide 11.0 1.00 1.00  0.61 0.9864172 0.9827625 1.0000000 #> 4  CYP2C9  S-warfarin 13.5 1.00 1.00  0.91 0.9889046 0.9859096 1.0000000 #> 5 CYP2C19  omeprazole 15.0 1.00 1.00  0.87 0.9900031 0.9873008 1.0000000 #> 6  CYP2D6        <NA>   NA   NA   NA    NA 1.0000000 1.0000000 1.0000000 #> 7  CYP3A4   midazolam 12.5 0.57 0.96  1.00 0.9880276 0.9847995 0.6141621 #>          Bh Cg Ch     aucr  risk #> 1 1.0000000  1  1 1.000000 FALSE #> 2 1.0000000  1  1       NA    NA #> 3 1.0000000  1  1 1.010627 FALSE #> 4 1.0000000  1  1 1.012989 FALSE #> 5 1.0000000  1  1 1.011172 FALSE #> 6 1.0000000  1  1       NA    NA #> 7 0.4757909  1  1 2.456990  TRUE"},{"path":"/reference/mech_stat_cyp_risk_table.html","id":null,"dir":"Reference","previous_headings":"","what":"CYP perpetration risk table as per mechanistic-static modeling — mech_stat_cyp_risk_table","title":"CYP perpetration risk table as per mechanistic-static modeling — mech_stat_cyp_risk_table","text":"CYP perpetration risk table per mechanistic-static modeling","code":""},{"path":"/reference/mech_stat_cyp_risk_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"CYP perpetration risk table as per mechanistic-static modeling — mech_stat_cyp_risk_table","text":"","code":"mech_stat_cyp_risk_table(   perp,   cyp_inh,   cyp_ind,   cyp_tdi = NULL,   include_induction = TRUE,   substr = cyp_reference_substrates,   kdeg = cyp_turnover,   na.rm = FALSE )"},{"path":"/reference/mech_stat_cyp_risk_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"CYP perpetration risk table as per mechanistic-static modeling — mech_stat_cyp_risk_table","text":"perp perpetrator object. cyp_inh CYP inhibition data data frame. cyp_ind CYP induction data data frame. cyp_tdi CYP TDI data data frame. include_induction Switch define whether induction included calculation (.e., C-terms per FDA guideline) substr CYP reference substrates used data frame, defaults cyp_reference_substrates. kdeg CYP turnover data data frame. Defaults built-reference data. na.rm Switch whether remove rows lacking ki data output, .e., ki == NA.","code":""},{"path":"/reference/mech_stat_cyp_risk_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"CYP perpetration risk table as per mechanistic-static modeling — mech_stat_cyp_risk_table","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/mech_stat_cyp_risk_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"CYP perpetration risk table as per mechanistic-static modeling — mech_stat_cyp_risk_table","text":"","code":"mech_stat_cyp_risk_table(   examplinib_parent,   examplinib_cyp_inhibition_data,   examplinib_cyp_induction_data) #>  #>  #> Table: Mechanistic static modeling of CYP inhibition risk for  examplinib #>  #> |CYP     | $K_{i,u}$|substrate   | $F_{gut}$| $f_m$| $f_{m,CYP}$| $A_g$| $A_h$| $B_g$| $B_h$| $C_g$| $C_h$|AUCR  |risk  | #> |:-------|---------:|:-----------|---------:|-----:|-----------:|-----:|-----:|-----:|-----:|-----:|-----:|:-----|:-----| #> |CYP1A2  |        NA|tizanidine  |      1.00|  0.95|        0.98|  1.00|  1.00|     1|     1|   1.0|   1.0|1.000 |FALSE | #> |CYP2B6  |        NA|NA          |        NA|    NA|          NA|  1.00|  1.00|     1|     1|   1.0|   1.0|NA    |NA    | #> |CYP2C8  |      11.0|repaglinide |      1.00|  1.00|        0.61|  0.99|  0.98|     1|     1|   1.0|   1.0|1.011 |FALSE | #> |CYP2C9  |      13.5|S-warfarin  |      1.00|  1.00|        0.91|  0.99|  0.99|     1|     1|   1.0|   1.0|1.013 |FALSE | #> |CYP2C19 |      15.0|omeprazole  |      1.00|  1.00|        0.87|  0.99|  0.99|     1|     1|   1.0|   1.0|1.011 |FALSE | #> |CYP2D6  |        NA|NA          |        NA|    NA|          NA|  1.00|  1.00|     1|     1|   1.0|   1.0|NA    |NA    | #> |CYP3A4  |      12.5|midazolam   |      0.57|  0.96|        1.00|  0.99|  0.98|     1|     1|   1.6|   1.8|0.463 |TRUE  | mech_stat_cyp_risk_table(   examplinib_parent,   examplinib_cyp_inhibition_data,   examplinib_cyp_induction_data,   examplinib_cyp_tdi_data) #>  #>  #> Table: Mechanistic static modeling of CYP inhibition risk for  examplinib #>  #> |CYP     | $K_{i,u}$|substrate   | $F_{gut}$| $f_m$| $f_{m,CYP}$| $A_g$| $A_h$| $B_g$| $B_h$| $C_g$| $C_h$|AUCR |risk  | #> |:-------|---------:|:-----------|---------:|-----:|-----------:|-----:|-----:|-----:|-----:|-----:|-----:|:----|:-----| #> |CYP1A2  |        NA|tizanidine  |      1.00|  0.95|        0.98|  1.00|  1.00|  1.00|  1.00|   1.0|   1.0|1.00 |FALSE | #> |CYP2B6  |        NA|NA          |        NA|    NA|          NA|  1.00|  1.00|  1.00|  1.00|   1.0|   1.0|NA   |NA    | #> |CYP2C8  |      11.0|repaglinide |      1.00|  1.00|        0.61|  0.99|  0.98|  1.00|  1.00|   1.0|   1.0|1.01 |FALSE | #> |CYP2C9  |      13.5|S-warfarin  |      1.00|  1.00|        0.91|  0.99|  0.99|  1.00|  1.00|   1.0|   1.0|1.01 |FALSE | #> |CYP2C19 |      15.0|omeprazole  |      1.00|  1.00|        0.87|  0.99|  0.99|  1.00|  1.00|   1.0|   1.0|1.01 |FALSE | #> |CYP2D6  |        NA|NA          |        NA|    NA|          NA|  1.00|  1.00|  1.00|  1.00|   1.0|   1.0|NA   |NA    | #> |CYP3A4  |      12.5|midazolam   |      0.57|  0.96|        1.00|  0.99|  0.98|  0.61|  0.48|   1.6|   1.8|1.20 |FALSE |"},{"path":"/reference/name.html","id":null,"dir":"Reference","previous_headings":"","what":"Generic name method — name","title":"Generic name method — name","text":"Generic name method","code":""},{"path":"/reference/name.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Generic name method — name","text":"","code":"name(obj)"},{"path":"/reference/name.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Generic name method — name","text":"obj perpetrator object.","code":""},{"path":"/reference/name.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Generic name method — name","text":"name perpetrator character.","code":""},{"path":"/reference/name.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Name of a perpetrator compound — name.perpetrator","title":"Name of a perpetrator compound — name.perpetrator","text":"Name perpetrator compound","code":""},{"path":"/reference/name.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Name of a perpetrator compound — name.perpetrator","text":"","code":"# S3 method for perpetrator name(obj)"},{"path":"/reference/name.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Name of a perpetrator compound — name.perpetrator","text":"obj perpetrator object.","code":""},{"path":"/reference/name.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Name of a perpetrator compound — name.perpetrator","text":"name perpetrator character.","code":""},{"path":"/reference/name.perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Name of a perpetrator compound — name.perpetrator","text":"","code":"name(examplinib_parent) #> [1] \"examplinib\""},{"path":[]},{"path":"/reference/names_string.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Perpetrator names as comma-separated string — names_string","text":"","code":"names_string(perps)"},{"path":"/reference/names_string.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Perpetrator names as comma-separated string — names_string","text":"perps perpetrator objects list.","code":""},{"path":"/reference/names_string.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Perpetrator names as comma-separated string — names_string","text":"output string.","code":""},{"path":"/reference/new_perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Perpetrator object constructor — new_perpetrator","title":"Perpetrator object constructor — new_perpetrator","text":"function converts data frame perpetrator object.","code":""},{"path":"/reference/new_perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Perpetrator object constructor — new_perpetrator","text":"","code":"new_perpetrator(df)"},{"path":"/reference/new_perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Perpetrator object constructor — new_perpetrator","text":"df data frame converted perpetrator object. See 'Details' expected format fields.","code":""},{"path":"/reference/new_perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Perpetrator object constructor — new_perpetrator","text":"perpetrator object.","code":""},{"path":"/reference/new_perpetrator.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Perpetrator object constructor — new_perpetrator","text":"input data frame columns 'param', 'value' source'. Rows following parameters ('param') expected input: following example example valid input data frame:","code":"param      value        source 1        name examplinib 2        type     parent 3          mw      492.6 4        dose        450 clinical dose 5      imaxss       3530     study 001 6          fu      0.023     study 002 7       fumic          1       default 8          rb          1     study 003 9          fa       0.81     study 003 10         fg          1       default 11         ka    0.00267       unknown 12 solubility        Inf       default"},{"path":[]},{"path":"/reference/print.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Implementation of the generic print function for perpetrator objects — print.perpetrator","title":"Implementation of the generic print function for perpetrator objects — print.perpetrator","text":"Implementation generic print function perpetrator objects","code":""},{"path":"/reference/print.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Implementation of the generic print function for perpetrator objects — print.perpetrator","text":"","code":"# S3 method for perpetrator print(x, ...)"},{"path":"/reference/print.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Implementation of the generic print function for perpetrator objects — print.perpetrator","text":"x perpetrator object. ... parameters.","code":""},{"path":"/reference/print.perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Implementation of the generic print function for perpetrator objects — print.perpetrator","text":"","code":"print(examplinib_parent) #> == DDI perpetrator object == #> name         examplinib                    #> oral         TRUE                          #> mw           492.6                         #> dose         450          clinical dose    #> imaxss       3530         study 001        #> fu           0.023        study 002        #> fumic        1            default          #> rb           1            study 003        #> fa           0.81         study 003        #> fg           1            default          #> ka           0.00267      unknown          #> solubility   Inf          default"},{"path":"/reference/property_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Generic function to display compound properties — property_table","title":"Generic function to display compound properties — property_table","text":"Generic function display compound properties","code":""},{"path":"/reference/property_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Generic function to display compound properties — property_table","text":"","code":"property_table(obj)"},{"path":"/reference/property_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Generic function to display compound properties — property_table","text":"obj object (compound object list thereof)","code":""},{"path":[]},{"path":"/reference/property_table.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Perpetrator drug properties for a list of compounds — property_table.list","title":"Perpetrator drug properties for a list of compounds — property_table.list","text":"function generates list markdown-formatted tables key properties list perpetrator objects.","code":""},{"path":"/reference/property_table.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Perpetrator drug properties for a list of compounds — property_table.list","text":"","code":"# S3 method for list property_table(obj)"},{"path":"/reference/property_table.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Perpetrator drug properties for a list of compounds — property_table.list","text":"obj list perpetrator objects.","code":""},{"path":"/reference/property_table.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Perpetrator drug properties for a list of compounds — property_table.list","text":"list markdown-formatted tables.","code":""},{"path":"/reference/property_table.list.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Perpetrator drug properties for a list of compounds — property_table.list","text":"","code":"property_table(examplinib_compounds) #>  #>  #> Table: Compound parameters for examplinib #>  #> |parameter            |value   |source        | #> |:--------------------|:-------|:-------------| #> |$MW$ (g/mol)         |492.6   |              | #> |$dose$ (mg)          |450     |clinical dose | #> |$C_{max,ss}$ (ng/ml) |3530    |study 001     | #> |$f_u$                |0.023   |study 002     | #> |$f_{u,mic}$          |1       |default       | #> |$R_B$                |1       |study 003     | #> |$F_a$                |0.81    |study 003     | #> |$F_g$                |1       |default       | #> |$k_a$ (1/min)        |0.00267 |unknown       | #> |$solubility$ (mg/l)  |Inf     |default       | #>  #>  #> Table: Compound parameters for M1 #>  #> |parameter            |value  |source    | #> |:--------------------|:------|:---------| #> |$MW$ (g/mol)         |506.56 |          | #> |$dose$ (mg)          |NA     |          | #> |$C_{max,ss}$ (ng/ml) |1038   |study 001 | #> |$f_u$                |0.012  |study 002 | #> |$f_{u,mic}$          |1      |default   | #> |$R_B$                |1      |study 002 | #> |$solubility$ (mg/l)  |Inf    |default   |"},{"path":"/reference/property_table.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of perpetrator drug properties — property_table.perpetrator","title":"Table of perpetrator drug properties — property_table.perpetrator","text":"function generates markdown-formatted table key properties perpetrator object.","code":""},{"path":"/reference/property_table.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of perpetrator drug properties — property_table.perpetrator","text":"","code":"# S3 method for perpetrator property_table(obj)"},{"path":"/reference/property_table.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of perpetrator drug properties — property_table.perpetrator","text":"obj perpetrator object.","code":""},{"path":"/reference/property_table.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of perpetrator drug properties — property_table.perpetrator","text":"markdown-formatted table.","code":""},{"path":"/reference/property_table.perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of perpetrator drug properties — property_table.perpetrator","text":"","code":"property_table(examplinib_parent) #>  #>  #> Table: Compound parameters for examplinib #>  #> |parameter            |value   |source        | #> |:--------------------|:-------|:-------------| #> |$MW$ (g/mol)         |492.6   |              | #> |$dose$ (mg)          |450     |clinical dose | #> |$C_{max,ss}$ (ng/ml) |3530    |study 001     | #> |$f_u$                |0.023   |study 002     | #> |$f_{u,mic}$          |1       |default       | #> |$R_B$                |1       |study 003     | #> |$F_a$                |0.81    |study 003     | #> |$F_g$                |1       |default       | #> |$k_a$ (1/min)        |0.00267 |unknown       | #> |$solubility$ (mg/l)  |Inf     |default       | property_table(examplinib_metabolite) #>  #>  #> Table: Compound parameters for M1 #>  #> |parameter            |value  |source    | #> |:--------------------|:------|:---------| #> |$MW$ (g/mol)         |506.56 |          | #> |$dose$ (mg)          |NA     |          | #> |$C_{max,ss}$ (ng/ml) |1038   |study 001 | #> |$f_u$                |0.012  |study 002 | #> |$f_{u,mic}$          |1      |default   | #> |$R_B$                |1      |study 002 | #> |$solubility$ (mg/l)  |Inf    |default   |"},{"path":"/reference/read_cyp_inhibitor_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Read CYP inhibition data — read_cyp_inhibitor_data","title":"Read CYP inhibition data — read_cyp_inhibitor_data","text":"Read CYP inhibition data file text connection.","code":""},{"path":"/reference/read_cyp_inhibitor_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Read CYP inhibition data — read_cyp_inhibitor_data","text":"","code":"read_cyp_inhibitor_data(source)"},{"path":"/reference/read_cyp_inhibitor_data.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Read CYP inhibition data — read_cyp_inhibitor_data","text":"source file text connection read .","code":""},{"path":"/reference/read_cyp_inhibitor_data.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Read CYP inhibition data — read_cyp_inhibitor_data","text":"data frame.","code":""},{"path":"/reference/read_cyp_inhibitor_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Read CYP inhibition data — read_cyp_inhibitor_data","text":"following, comma-separated fields expected (order): 'name' perpetrator compound name 'cyp' UGT enzyme (upper case) character. 'ki' \\(k_i\\) 'source' Optional source information character. Lines starting '#' considered comments evaluated. following example valid input:","code":"# PARENT # compound, CYP, ki, source examplinib, CYP1A2,  NA, examplinib, CYP2B6,  NA, examplinib, CYP2C8,  11,   study 001 examplinib, CYP2C9,  13.5, study 001 examplinib, CYP2C19, 15,   study 001 examplinib, CYP2D6,  NA, examplinib, CYP3A4,  12.5, study 001 # METABOLITE M1,         CYP2C9,  4.4,  study 002"},{"path":"/reference/read_cyp_inhibitor_data.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Read CYP inhibition data — read_cyp_inhibitor_data","text":"","code":"read_cyp_inhibitor_data(textConnection(examplinib_cyp_inhibition_string)) #>         name     cyp   ki    source #> 1 examplinib  CYP1A2   NA           #> 2 examplinib  CYP2B6   NA           #> 3 examplinib  CYP2C8   11 study 001 #> 4 examplinib  CYP2C9 13.5 study 001 #> 5 examplinib CYP2C19   15 study 001 #> 6 examplinib  CYP2D6   NA           #> 7 examplinib  CYP3A4 12.5 study 001 #> 8         M1  CYP2C9  4.4 study 002"},{"path":"/reference/read_inducer_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Read csv-formatted CYP inducer data — read_inducer_data","title":"Read csv-formatted CYP inducer data — read_inducer_data","text":"function loads CYP inducer data csv file. following fields expected: 'name' name perpetrator compound character. 'cyp' CYP enzyme (upper case) character. 'emax' \\(E_{max}\\), .e., maximum induction effect determined vitro numeric. 'ec50' \\(EC_{50}\\) µM numeric. 'maxc' maximal concentration µM tested vitro assay numeric. 'source' Optional source information character.","code":""},{"path":"/reference/read_inducer_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Read csv-formatted CYP inducer data — read_inducer_data","text":"","code":"read_inducer_data(source)"},{"path":"/reference/read_inducer_data.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Read csv-formatted CYP inducer data — read_inducer_data","text":"source connection read .","code":""},{"path":"/reference/read_inducer_data.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Read csv-formatted CYP inducer data — read_inducer_data","text":"data data frame.","code":""},{"path":"/reference/read_inducer_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Read csv-formatted CYP inducer data — read_inducer_data","text":"Comment lines must start '#'. valid source , e.g.,","code":"# PARENT # compound, CYP,     Emax, EC50, max c, source examplinib, CYP1A2,  1,    NA,   5,     study 007 examplinib, CYP2B6,  1,    NA,   5,     study 007 examplinib, CYP2C8,  NA,   NA,   NA, examplinib, CYP2C9,  NA,   NA,   NA, examplinib, CYP2C19, NA,   NA,   NA, examplinib, CYP2D6,  NA,   NA,   NA, examplinib, CYP3A4,   7.35, 1.64, 3,    study 007  # METABOLITE M1, CYP1A2,  1,    NA,   5,  study 007 M1, CYP2B6,  6.98, 1.86, 5,  study 007 M1, CYP2C8,  NA,   NA,   NA, M1, CYP2C9,  NA,   NA,   NA, M1, CYP2C19, NA,   NA,   NA, M1, CYP2D6,  NA,   NA,   NA, M1, CYP3A4,  22.7, 1.1,  5,  study 007"},{"path":"/reference/read_inducer_data.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Read csv-formatted CYP inducer data — read_inducer_data","text":"","code":"read_inducer_data(textConnection(examplinib_cyp_induction_string)) #>          name     cyp  emax ec50 maxc    source #> 1  examplinib  CYP1A2  1.00   NA    5 study 007 #> 2  examplinib  CYP2B6  1.00   NA    5 study 007 #> 3  examplinib  CYP2C8    NA   NA   NA           #> 4  examplinib  CYP2C9    NA   NA   NA           #> 5  examplinib CYP2C19    NA   NA   NA           #> 6  examplinib  CYP2D6    NA   NA   NA           #> 7  examplinib  CYP3A4  7.35 1.64    3 study 007 #> 8          M1  CYP1A2  1.00   NA    5 study 007 #> 9          M1  CYP2B6  6.98 1.86    5 study 007 #> 10         M1  CYP2C8    NA   NA   NA           #> 11         M1  CYP2C9    NA   NA   NA           #> 12         M1 CYP2C19    NA   NA   NA           #> 13         M1  CYP2D6    NA   NA   NA           #> 14         M1  CYP3A4 22.70 1.10    5 study 007"},{"path":"/reference/read_inhibitor_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Read csv-formatted CYP inhibition data — read_inhibitor_data","title":"Read csv-formatted CYP inhibition data — read_inhibitor_data","text":"function deprecated favor read_cyp_inhibitor_data(), read_ugt_inhibitor_data() read_transporter_inhibitor_data().","code":""},{"path":"/reference/read_inhibitor_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Read csv-formatted CYP inhibition data — read_inhibitor_data","text":"","code":"read_inhibitor_data(source)"},{"path":"/reference/read_inhibitor_data.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Read csv-formatted CYP inhibition data — read_inhibitor_data","text":"source connection read .","code":""},{"path":"/reference/read_inhibitor_data.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Read csv-formatted CYP inhibition data — read_inhibitor_data","text":"data frame.","code":""},{"path":"/reference/read_inhibitor_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Read csv-formatted CYP inhibition data — read_inhibitor_data","text":"function loads CYP inhibition data csv file. expected fields (order) compound name, CYP enzyme, Ki source information respective data. latter field may remain empty. Comment lines must start '#'. valid source , e.g.,","code":"# PARENT # name,     CYP,     Ki,   source examplinib, CYP1A2,  NA, examplinib, CYP2B6,  NA, examplinib, CYP2C8,  11,   study 001 examplinib, CYP2C9,  13.5, study 001 examplinib, CYP2C19, 15,   study 001 examplinib, CYP2D6,  NA, examplinib, CYP3A4,  12.5, study 001 # METABOLITE # name,     CYP,     Ki,   source M1,         CYP2C9,  4.4,  study 002"},{"path":"/reference/read_perpetrators.html","id":null,"dir":"Reference","previous_headings":"","what":"Read perpetrator information from file or text string — read_perpetrators","title":"Read perpetrator information from file or text string — read_perpetrators","text":"input source can either file name string text connection. can used read compound data string.","code":""},{"path":"/reference/read_perpetrators.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Read perpetrator information from file or text string — read_perpetrators","text":"","code":"read_perpetrators(source)"},{"path":"/reference/read_perpetrators.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Read perpetrator information from file or text string — read_perpetrators","text":"source connection read .","code":""},{"path":"/reference/read_perpetrators.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Read perpetrator information from file or text string — read_perpetrators","text":"list perpetrator objects.","code":""},{"path":"/reference/read_perpetrators.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Read perpetrator information from file or text string — read_perpetrators","text":"file expected comply following: Comments start '#' go end line lines format: drug, parameter, value, source fields within line comma-separated fields plain text without enclosing \"\" source field reference usually refers clinical non-clinical study report. source field may remain empty. Note line ends comma. metabolites, fields dose, fa, fg ka relevant filled NA. metabolites, 'oral' must 'FALSE'. Note multiple compounds, e.g., parent metabolites may included perpetrator file. typical compound file look e.g., like :","code":"# name, param, value, source   # parent    examplinib,  oral,     TRUE,   examplinib,  mw,       492.6,   examplinib,  dose,     450,       clinical dose   examplinib,  imaxss,   3530,      study 001   examplinib,  fu,       0.023,     study 002   examplinib,  fumic,    1,         default   examplinib,  rb,       1,         study 003   examplinib,  fa,       0.81,      study 003   examplinib,  fg,       1,         default   examplinib,  ka,       0.00267,   unknown    # metabolite    M1,  oral,   FALSE,   M1,  mw,     506.56,   M1,  dose,   NA,   M1,  imaxss, 1038,      study 001   M1,  fu,     0.012,     study 002   M1,  fumic,  1,         default   M1,  rb,     1,         study 002   M1,  fa,     NA,   M1,  fg,     NA,   M1,  ka,     NA,"},{"path":"/reference/read_perpetrators.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Read perpetrator information from file or text string — read_perpetrators","text":"","code":"read_perpetrators(textConnection(examplinib_compounds_string)) #> $M1 #> == DDI perpetrator object == #> name         M1                    #> oral         FALSE                 #> mw           506.56                #> dose         NA                    #> imaxss       1038     study 001    #> fu           0.012    study 002    #> fumic        1        default      #> rb           1        study 002    #> fa           NA                    #> fg           NA                    #> ka           NA                    #> solubility   Inf      default #> $examplinib #> == DDI perpetrator object == #> name         examplinib                    #> oral         TRUE                          #> mw           492.6                         #> dose         450          clinical dose    #> imaxss       3530         study 001        #> fu           0.023        study 002        #> fumic        1            default          #> rb           1            study 003        #> fa           0.81         study 003        #> fg           1            default          #> ka           0.00267      unknown          #> solubility   Inf          default"},{"path":"/reference/read_tdi_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Read csv-formatted CYP TDI data — read_tdi_data","title":"Read csv-formatted CYP TDI data — read_tdi_data","text":"function reads comma-separated CYP TDI data file text connection.","code":""},{"path":"/reference/read_tdi_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Read csv-formatted CYP TDI data — read_tdi_data","text":"","code":"read_tdi_data(source)"},{"path":"/reference/read_tdi_data.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Read csv-formatted CYP TDI data — read_tdi_data","text":"source connection read .","code":""},{"path":"/reference/read_tdi_data.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Read csv-formatted CYP TDI data — read_tdi_data","text":"data frame.","code":""},{"path":"/reference/read_tdi_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Read csv-formatted CYP TDI data — read_tdi_data","text":"following fields expected (order): 'name' perpetrator compound name character. 'cyp' CYP enzyme character. 'ki' \\(K_I\\) \\(\\mu M\\) numeric. 'kinact' \\(k_{inact}\\) \\(1/h\\) numeric. 'source' Optional source information character. Lines starting '#' interpreted comments evaluated. valid data set , e.g.,","code":"# compound, CYP,    ki,   kinact, source examplinib, CYP3A4, 0.17, 0.04, study 001"},{"path":"/reference/read_transporter_inhibitor_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Read transporter inhibition data — read_transporter_inhibitor_data","title":"Read transporter inhibition data — read_transporter_inhibitor_data","text":"Read transporter inhibition data file text connection.","code":""},{"path":"/reference/read_transporter_inhibitor_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Read transporter inhibition data — read_transporter_inhibitor_data","text":"","code":"read_transporter_inhibitor_data(source)"},{"path":"/reference/read_transporter_inhibitor_data.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Read transporter inhibition data — read_transporter_inhibitor_data","text":"source file text connection read .","code":""},{"path":"/reference/read_transporter_inhibitor_data.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Read transporter inhibition data — read_transporter_inhibitor_data","text":"data frame.","code":""},{"path":"/reference/read_transporter_inhibitor_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Read transporter inhibition data — read_transporter_inhibitor_data","text":"following, comma-separated fields expected (order): 'name' perpetrator compound name 'cyp' UGT enzyme (upper case) character. 'ic50' \\(IC_{50}\\) inhibition μM. 'source' Optional source information character. Lines starting '#' considered comments evaluated. following example valid input:","code":"# PARENT # name,     transporter, IC50, source examplinib, Pgp,         0.41, study 005 examplinib, BCRP,        1.9,  study 005 examplinib, OCT1,        2.3,  study 006 examplinib, OATP1B1,     177,  study 006 examplinib, OATP1B3,     35,   study 006 examplinib, OAT1,        271, examplinib, OAT3,        300, examplinib, BSEP,        12.8, examplinib, OCT2,        67,   study 006 examplinib, MATE1,       3.6,  study 006 examplinib, MATE2k,      1.1,  study 006"},{"path":"/reference/read_transporter_inhibitor_data.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Read transporter inhibition data — read_transporter_inhibitor_data","text":"","code":"read_transporter_inhibitor_data(textConnection(examplinib_transporter_inhibition_string)) #>          name transporter ic50    source #> 1  examplinib         Pgp 0.41 study 005 #> 2  examplinib        BCRP  1.9 study 005 #> 3  examplinib        OCT1  2.3 study 006 #> 4  examplinib     OATP1B1  177 study 006 #> 5  examplinib     OATP1B3   35 study 006 #> 6  examplinib        OAT1  271           #> 7  examplinib        OAT3  300           #> 8  examplinib        BSEP 12.8           #> 9  examplinib        OCT2   67 study 006 #> 10 examplinib       MATE1  3.6 study 006 #> 11 examplinib      MATE2k  1.1 study 006"},{"path":"/reference/read_ugt_inhibitor_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Read UGT inhibition data — read_ugt_inhibitor_data","title":"Read UGT inhibition data — read_ugt_inhibitor_data","text":"Read UGT inhibition data file text connection.","code":""},{"path":"/reference/read_ugt_inhibitor_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Read UGT inhibition data — read_ugt_inhibitor_data","text":"","code":"read_ugt_inhibitor_data(source)"},{"path":"/reference/read_ugt_inhibitor_data.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Read UGT inhibition data — read_ugt_inhibitor_data","text":"source file text connection read .","code":""},{"path":"/reference/read_ugt_inhibitor_data.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Read UGT inhibition data — read_ugt_inhibitor_data","text":"data frame.","code":""},{"path":"/reference/read_ugt_inhibitor_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Read UGT inhibition data — read_ugt_inhibitor_data","text":"following, comma-separated fields expected input: 'name' perpetrator compound name 'ugt' UGT enzyme (upper case) character. 'ic50' \\(IC_{50}\\) 'source' Optional source information character. Lines starting '#' considered comments evaluated. following example valid input:","code":"# PARENT # compound, enzyme, IC50, source examplinib, UGT1A1, 15, study 009 examplinib, UGT1A3, 15, study 009 examplinib, UGT1A4, 15, study 009 examplinib, UGT1A6, 15, study 009 examplinib, UGT1A9, 3.8, study 009 examplinib, UGT2B7, 15, study 009 examplinib, UGT2B15, 15, study 009 examplinib, UGT2B17, 6.1, study 009 # METABOLITE # compound, enzyme, IC50, source M1, UGT1A1, 1.1, study 009 M1, UGT1A3, 5.8, study 009 M1, UGT1A4, 6.2, study 009 M1, UGT1A6, 15, study 009 M1, UGT1A9, 3.6, study 009 M1, UGT2B7, 15, study 009 M1, UGT2B15, 9.6, study 009"},{"path":"/reference/read_ugt_inhibitor_data.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Read UGT inhibition data — read_ugt_inhibitor_data","text":"","code":"read_ugt_inhibitor_data(textConnection(examplinib_ugt_inhibition_string)) #>          name     ugt ic50    source #> 1  examplinib  UGT1A1   15 study 009 #> 2  examplinib  UGT1A3   15 study 009 #> 3  examplinib  UGT1A4   15 study 009 #> 4  examplinib  UGT1A6   15 study 009 #> 5  examplinib  UGT1A9  3.8 study 009 #> 6  examplinib  UGT2B7   15 study 009 #> 7  examplinib UGT2B15   15 study 009 #> 8  examplinib UGT2B17  6.1 study 009 #> 9          M1  UGT1A1  1.1 study 009 #> 10         M1  UGT1A3  5.8 study 009 #> 11         M1  UGT1A4  6.2 study 009 #> 12         M1  UGT1A6   15 study 009 #> 13         M1  UGT1A9  3.6 study 009 #> 14         M1  UGT2B7   15 study 009 #> 15         M1 UGT2B15  9.6 study 009"},{"path":"/reference/static_cyp_induction_risk.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic static CYP induction risk — static_cyp_induction_risk","title":"Basic static CYP induction risk — static_cyp_induction_risk","text":"Basic static CYP induction risk","code":""},{"path":"/reference/static_cyp_induction_risk.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic static CYP induction risk — static_cyp_induction_risk","text":"","code":"static_cyp_induction_risk(perp, cyp_ind)"},{"path":"/reference/static_cyp_induction_risk.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic static CYP induction risk — static_cyp_induction_risk","text":"perp perpetrator object list thereof. cyp_ind CYP induction data data frame. following fields expected: 'name' name perpetrator compound character. 'cyp' CYP enzyme (upper case) character. 'emax' \\(E_{max}\\), .e., maximum induction effect determined vitro numeric. 'ec50' \\(EC_{50}\\) µM numeric. 'maxc' maximal concentration µM tested vitro assay numeric. 'source' Optional source information character.","code":""},{"path":"/reference/static_cyp_induction_risk.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic static CYP induction risk — static_cyp_induction_risk","text":"data frame.","code":""},{"path":"/reference/static_cyp_induction_risk.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Basic static CYP induction risk — static_cyp_induction_risk","text":"basic (EMA) fold-change (FDA) methods evaluate whether maximal fold-change mRNA expression > 2-fold expected unbound hepatic concentration drug. Regarding relevant drug concentrations, FDA guidance suggests considering \\(30*I_{max,ss,u}\\) EMA guidance considers \\(50*I_{max,ss,u}\\) hepatic \\(0.1*I_{gut}\\) intestinal CYP enzyme induction. expected concentrations respective vitro assays cover concentrations.","code":""},{"path":"/reference/static_cyp_induction_risk.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic static CYP induction risk — static_cyp_induction_risk","text":"","code":"static_cyp_induction_risk(examplinib_parent, examplinib_cyp_induction_data) #>       cyp emax maxc    source maxc_imaxssu  risk #> 1  CYP1A2 1.00    5 study 007         30.3 FALSE #> 2  CYP2B6 1.00    5 study 007         30.3 FALSE #> 3  CYP2C8   NA   NA                     NA    NA #> 4  CYP2C9   NA   NA                     NA    NA #> 5 CYP2C19   NA   NA                     NA    NA #> 6  CYP2D6   NA   NA                     NA    NA #> 7  CYP3A4 7.35    3 study 007         18.2  TRUE #>                                                         note #> 1     Maximal tested concentration is below FDA expectations #> 2     Maximal tested concentration is below FDA expectations #> 3                                                            #> 4                                                            #> 5                                                            #> 6                                                            #> 7 Maximal tested concentration is below EMA/FDA expectations"},{"path":"/reference/static_cyp_induction_risk.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic static CYP induction risk — static_cyp_induction_risk.list","title":"Basic static CYP induction risk — static_cyp_induction_risk.list","text":"Basic static CYP induction risk","code":""},{"path":"/reference/static_cyp_induction_risk.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic static CYP induction risk — static_cyp_induction_risk.list","text":"","code":"# S3 method for list static_cyp_induction_risk(perp, cyp_ind)"},{"path":"/reference/static_cyp_induction_risk.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic static CYP induction risk — static_cyp_induction_risk.list","text":"perp perpetrator object list thereof. cyp_ind CYP induction data data frame.","code":""},{"path":"/reference/static_cyp_induction_risk.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic static CYP induction risk — static_cyp_induction_risk.list","text":"data frame.","code":""},{"path":"/reference/static_cyp_induction_risk.list.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic static CYP induction risk — static_cyp_induction_risk.list","text":"","code":"static_cyp_induction_risk(examplinib_compounds, examplinib_cyp_induction_data) #> $examplinib #>       cyp emax maxc    source maxc_imaxssu  risk #> 1  CYP1A2 1.00    5 study 007         30.3 FALSE #> 2  CYP2B6 1.00    5 study 007         30.3 FALSE #> 3  CYP2C8   NA   NA                     NA    NA #> 4  CYP2C9   NA   NA                     NA    NA #> 5 CYP2C19   NA   NA                     NA    NA #> 6  CYP2D6   NA   NA                     NA    NA #> 7  CYP3A4 7.35    3 study 007         18.2  TRUE #>                                                         note #> 1     Maximal tested concentration is below FDA expectations #> 2     Maximal tested concentration is below FDA expectations #> 3                                                            #> 4                                                            #> 5                                                            #> 6                                                            #> 7 Maximal tested concentration is below EMA/FDA expectations #>  #> $M1 #>       cyp  emax maxc    source maxc_imaxssu  risk note #> 1  CYP1A2  1.00    5 study 007        203.3 FALSE      #> 2  CYP2B6  6.98    5 study 007        203.3  TRUE      #> 3  CYP2C8    NA   NA                     NA    NA      #> 4  CYP2C9    NA   NA                     NA    NA      #> 5 CYP2C19    NA   NA                     NA    NA      #> 6  CYP2D6    NA   NA                     NA    NA      #> 7  CYP3A4 22.70    5 study 007        203.3  TRUE      #>"},{"path":"/reference/static_cyp_induction_risk.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Basic static CYP induction risk — static_cyp_induction_risk.perpetrator","title":"Basic static CYP induction risk — static_cyp_induction_risk.perpetrator","text":"Basic static CYP induction risk","code":""},{"path":"/reference/static_cyp_induction_risk.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Basic static CYP induction risk — static_cyp_induction_risk.perpetrator","text":"","code":"# S3 method for perpetrator static_cyp_induction_risk(perp, cyp_ind)"},{"path":"/reference/static_cyp_induction_risk.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Basic static CYP induction risk — static_cyp_induction_risk.perpetrator","text":"perp perpetrator object list thereof. cyp_ind CYP induction data data frame.","code":""},{"path":"/reference/static_cyp_induction_risk.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Basic static CYP induction risk — static_cyp_induction_risk.perpetrator","text":"data frame.","code":""},{"path":"/reference/static_cyp_induction_risk.perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Basic static CYP induction risk — static_cyp_induction_risk.perpetrator","text":"","code":"static_cyp_induction_risk(examplinib_parent, examplinib_cyp_induction_data) #>       cyp emax maxc    source maxc_imaxssu  risk #> 1  CYP1A2 1.00    5 study 007         30.3 FALSE #> 2  CYP2B6 1.00    5 study 007         30.3 FALSE #> 3  CYP2C8   NA   NA                     NA    NA #> 4  CYP2C9   NA   NA                     NA    NA #> 5 CYP2C19   NA   NA                     NA    NA #> 6  CYP2D6   NA   NA                     NA    NA #> 7  CYP3A4 7.35    3 study 007         18.2  TRUE #>                                                         note #> 1     Maximal tested concentration is below FDA expectations #> 2     Maximal tested concentration is below FDA expectations #> 3                                                            #> 4                                                            #> 5                                                            #> 6                                                            #> 7 Maximal tested concentration is below EMA/FDA expectations"},{"path":"/reference/static_cyp_induction_risk_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table","text":"Table basic static CYP induction risk","code":""},{"path":"/reference/static_cyp_induction_risk_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table","text":"","code":"static_cyp_induction_risk_table(perp, cyp_ind, na.rm = F)"},{"path":"/reference/static_cyp_induction_risk_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table","text":"perp perpetrator object. cyp_ind CYP induction data data frame. See static_cyp_induction_risk() details. na.rm Remove rows lacking ki data (.e., ki == NA).","code":""},{"path":"/reference/static_cyp_induction_risk_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/static_cyp_induction_risk_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table","text":"","code":"static_cyp_induction_risk_table(examplinib_parent, examplinib_cyp_induction_data) #>  #>  #> Table: Risk for hepatic CYP induction by examplinib (basic static model) #>  #> |CYP     | $E_{max}$| $max c$ (µM)|source    | $max c/I_{max,ss,u}$|risk  |notes                                                      | #> |:-------|---------:|------------:|:---------|--------------------:|:-----|:----------------------------------------------------------| #> |CYP1A2  |      1.00|            5|study 007 |                 30.3|FALSE |Maximal tested concentration is below FDA expectations     | #> |CYP2B6  |      1.00|            5|study 007 |                 30.3|FALSE |Maximal tested concentration is below FDA expectations     | #> |CYP2C8  |        NA|           NA|          |                   NA|NA    |                                                           | #> |CYP2C9  |        NA|           NA|          |                   NA|NA    |                                                           | #> |CYP2C19 |        NA|           NA|          |                   NA|NA    |                                                           | #> |CYP2D6  |        NA|           NA|          |                   NA|NA    |                                                           | #> |CYP3A4  |      7.35|            3|study 007 |                 18.2|TRUE  |Maximal tested concentration is below EMA/FDA expectations |"},{"path":"/reference/static_cyp_induction_risk_table.list.html","id":null,"dir":"Reference","previous_headings":"","what":"Tables of the basic static CYP induction risk — static_cyp_induction_risk_table.list","title":"Tables of the basic static CYP induction risk — static_cyp_induction_risk_table.list","text":"Tables basic static CYP induction risk","code":""},{"path":"/reference/static_cyp_induction_risk_table.list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Tables of the basic static CYP induction risk — static_cyp_induction_risk_table.list","text":"","code":"# S3 method for list static_cyp_induction_risk_table(perp, cyp_ind, na.rm = F)"},{"path":"/reference/static_cyp_induction_risk_table.list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Tables of the basic static CYP induction risk — static_cyp_induction_risk_table.list","text":"perp list perpetrator objects. cyp_ind CYP induction data data frame. na.rm Remove rows lacking ki data (.e., ki == NA).","code":""},{"path":"/reference/static_cyp_induction_risk_table.list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Tables of the basic static CYP induction risk — static_cyp_induction_risk_table.list","text":"list markdown-formatted tables.","code":""},{"path":"/reference/static_cyp_induction_risk_table.list.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Tables of the basic static CYP induction risk — static_cyp_induction_risk_table.list","text":"","code":"static_cyp_induction_risk_table(examplinib_compounds, examplinib_cyp_induction_data) #>  #>  #> Table: Risk for hepatic CYP induction by examplinib (basic static model) #>  #> |CYP     | $E_{max}$| $max c$|source    | $max c/I_{max,ss,u}$|risk  |notes                                                      | #> |:-------|---------:|-------:|:---------|--------------------:|:-----|:----------------------------------------------------------| #> |CYP1A2  |      1.00|       5|study 007 |                 30.3|FALSE |Maximal tested concentration is below FDA expectations     | #> |CYP2B6  |      1.00|       5|study 007 |                 30.3|FALSE |Maximal tested concentration is below FDA expectations     | #> |CYP2C8  |        NA|      NA|          |                   NA|NA    |                                                           | #> |CYP2C9  |        NA|      NA|          |                   NA|NA    |                                                           | #> |CYP2C19 |        NA|      NA|          |                   NA|NA    |                                                           | #> |CYP2D6  |        NA|      NA|          |                   NA|NA    |                                                           | #> |CYP3A4  |      7.35|       3|study 007 |                 18.2|TRUE  |Maximal tested concentration is below EMA/FDA expectations | #>  #>  #> Table: Risk for hepatic CYP induction by M1 (basic static model) #>  #> |CYP     | $E_{max}$| $max c$|source    | $max c/I_{max,ss,u}$|risk  |notes | #> |:-------|---------:|-------:|:---------|--------------------:|:-----|:-----| #> |CYP1A2  |      1.00|       5|study 007 |                203.3|FALSE |      | #> |CYP2B6  |      6.98|       5|study 007 |                203.3|TRUE  |      | #> |CYP2C8  |        NA|      NA|          |                   NA|NA    |      | #> |CYP2C9  |        NA|      NA|          |                   NA|NA    |      | #> |CYP2C19 |        NA|      NA|          |                   NA|NA    |      | #> |CYP2D6  |        NA|      NA|          |                   NA|NA    |      | #> |CYP3A4  |     22.70|       5|study 007 |                203.3|TRUE  |      |"},{"path":"/reference/static_cyp_induction_risk_table.perpetrator.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table.perpetrator","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table.perpetrator","text":"Table basic static CYP induction risk","code":""},{"path":"/reference/static_cyp_induction_risk_table.perpetrator.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table.perpetrator","text":"","code":"# S3 method for perpetrator static_cyp_induction_risk_table(perp, cyp_ind, na.rm = F)"},{"path":"/reference/static_cyp_induction_risk_table.perpetrator.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table.perpetrator","text":"perp perpetrator object. cyp_ind CYP induction data data frame. na.rm Remove rows lacking ki data (.e., ki == NA).","code":""},{"path":"/reference/static_cyp_induction_risk_table.perpetrator.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table.perpetrator","text":"markdown-formatted table.","code":""},{"path":"/reference/static_cyp_induction_risk_table.perpetrator.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of the basic static CYP induction risk — static_cyp_induction_risk_table.perpetrator","text":"","code":"static_cyp_induction_risk_table(examplinib_parent, examplinib_cyp_induction_data) #>  #>  #> Table: Risk for hepatic CYP induction by examplinib (basic static model) #>  #> |CYP     | $E_{max}$| $max c$|source    | $max c/I_{max,ss,u}$|risk  |notes                                                      | #> |:-------|---------:|-------:|:---------|--------------------:|:-----|:----------------------------------------------------------| #> |CYP1A2  |      1.00|       5|study 007 |                 30.3|FALSE |Maximal tested concentration is below FDA expectations     | #> |CYP2B6  |      1.00|       5|study 007 |                 30.3|FALSE |Maximal tested concentration is below FDA expectations     | #> |CYP2C8  |        NA|      NA|          |                   NA|NA    |                                                           | #> |CYP2C9  |        NA|      NA|          |                   NA|NA    |                                                           | #> |CYP2C19 |        NA|      NA|          |                   NA|NA    |                                                           | #> |CYP2D6  |        NA|      NA|          |                   NA|NA    |                                                           | #> |CYP3A4  |      7.35|       3|study 007 |                 18.2|TRUE  |Maximal tested concentration is below EMA/FDA expectations |"},{"path":"/reference/transporter_inhibition_risk.html","id":null,"dir":"Reference","previous_headings":"","what":"Drug transporter inhibition risk — transporter_inhibition_risk","title":"Drug transporter inhibition risk — transporter_inhibition_risk","text":"Drug transporter inhibition risk","code":""},{"path":"/reference/transporter_inhibition_risk.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Drug transporter inhibition risk — transporter_inhibition_risk","text":"","code":"transporter_inhibition_risk(   perp,   transporter_inh,   transporter_ref = transporter_reference_data )"},{"path":"/reference/transporter_inhibition_risk.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Drug transporter inhibition risk — transporter_inhibition_risk","text":"perp perpetrator object. transporter_inh Transporter inhibition data data frame. following fields expected: 'name' perpetrator compound name 'cyp' UGT enzyme (upper case) character. 'ic50' \\(IC_{50}\\) inhibition μM. 'source' Optional source information character. transporter_ref Transporter reference data.","code":""},{"path":"/reference/transporter_inhibition_risk.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Drug transporter inhibition risk — transporter_inhibition_risk","text":"data frame.","code":""},{"path":"/reference/transporter_inhibition_risk.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Drug transporter inhibition risk — transporter_inhibition_risk","text":"relevant metric assessment transporter interactions \\(R=[]/K_i\\). vitro transporter inhibition studies, \\(IC_{50}\\) values experimentally determined. Since transporter substrate concentration usually kept low relation \\(K_m\\) minimize passive permeation, \\(K_i = IC_{50}\\) can assumed. relevant perpetrator concentrations \\([]\\) : \\(I_{gut}\\) intestinal P-gp BRCR \\(I_{max,inlet,u}\\) hepatic basolateral transporters OCT1, OATP1B1 OATP1B3 \\(I_{max,ss,u}\\) renal basolateral transporters OAT1, OAT3 OCT2, well apical transporters outside intestinal mucosa, .e., hepatic P-gp BCRP, MATE1, MATE2-k. Note FDA EMA guidelines differ definitions thresholds assumed clinically relevant effects.","code":""},{"path":[]},{"path":"/reference/transporter_inhibition_risk.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Drug transporter inhibition risk — transporter_inhibition_risk","text":"","code":"transporter_inhibition_risk(examplinib_parent, examplinib_transporter_inhibition_data) #>    transporter   ic50    source            r fda_thld fda_risk ema_thld #> 1      Pgp_int   0.41 study 005 8.912391e+03     10.0     TRUE    10.00 #> 2      Pgp_sys   0.41 study 005 4.019984e-01      0.1     TRUE     0.02 #> 3     BCRP_int   1.90 study 005 1.923200e+03     10.0     TRUE    10.00 #> 4     BCRP_sys   1.90 study 005 8.674701e-02      0.1    FALSE     0.02 #> 5         OCT1   2.30 study 006 8.388626e-02       NA       NA     0.04 #> 6      OATP1B1 177.00 study 006 1.090047e-03      0.1    FALSE     0.04 #> 7      OATP1B3  35.00 study 006 5.512525e-03      0.1    FALSE     0.04 #> 8         OAT1 271.00           6.081894e-04      0.1    FALSE     0.04 #> 9         OAT3 300.00           5.493978e-04      0.1    FALSE     0.04 #> 10        BSEP  12.80           1.287651e-02      0.1    FALSE     0.02 #> 11        OCT2  67.00 study 006 2.459990e-03      0.1    FALSE     0.02 #> 12       MATE1   3.60 study 006 4.578315e-02      0.1    FALSE     0.02 #> 13      MATE2k   1.10 study 006 1.498358e-01      0.1     TRUE     0.02 #>    ema_risk #> 1      TRUE #> 2      TRUE #> 3      TRUE #> 4      TRUE #> 5      TRUE #> 6     FALSE #> 7     FALSE #> 8     FALSE #> 9     FALSE #> 10    FALSE #> 11    FALSE #> 12     TRUE #> 13     TRUE"},{"path":"/reference/transporter_inhibition_risk_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Table of drug transporter inhibition risks — transporter_inhibition_risk_table","title":"Table of drug transporter inhibition risks — transporter_inhibition_risk_table","text":"Table drug transporter inhibition risks","code":""},{"path":"/reference/transporter_inhibition_risk_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Table of drug transporter inhibition risks — transporter_inhibition_risk_table","text":"","code":"transporter_inhibition_risk_table(   perp,   transporter_inh,   transporter_ref = transporter_reference_data,   na.rm = F )"},{"path":"/reference/transporter_inhibition_risk_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Table of drug transporter inhibition risks — transporter_inhibition_risk_table","text":"perp perpetrator object. transporter_inh Transporter inhibition data data frame. See transporter_inhibition_risk() details. transporter_ref Transporter reference data. na.rm Switch exlcude rows lacking \\(IC_{50}\\) data output.","code":""},{"path":"/reference/transporter_inhibition_risk_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Table of drug transporter inhibition risks — transporter_inhibition_risk_table","text":"markdown-formatted table.","code":""},{"path":[]},{"path":"/reference/transporter_inhibition_risk_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Table of drug transporter inhibition risks — transporter_inhibition_risk_table","text":"","code":"transporter_inhibition_risk_table(examplinib_parent, examplinib_transporter_inhibition_data) #>  #>  #> Table: Risk for drug transporter inhibition by examplinib #>  #> |transporter | $IC_{50}$|source    |      $R$| thld FDA|risk FDA | thld EMA|risk EMA | #> |:-----------|---------:|:---------|--------:|--------:|:--------|--------:|:--------| #> |Pgp_int     |      0.41|study 005 | 8912.391|     10.0|TRUE     |    10.00|TRUE     | #> |Pgp_sys     |      0.41|study 005 |    0.402|      0.1|TRUE     |     0.02|TRUE     | #> |BCRP_int    |      1.90|study 005 | 1923.200|     10.0|TRUE     |    10.00|TRUE     | #> |BCRP_sys    |      1.90|study 005 |    0.087|      0.1|FALSE    |     0.02|TRUE     | #> |OCT1        |      2.30|study 006 |    0.084|       NA|NA       |     0.04|TRUE     | #> |OATP1B1     |    177.00|study 006 |    0.001|      0.1|FALSE    |     0.04|FALSE    | #> |OATP1B3     |     35.00|study 006 |    0.006|      0.1|FALSE    |     0.04|FALSE    | #> |OAT1        |    271.00|          |    0.001|      0.1|FALSE    |     0.04|FALSE    | #> |OAT3        |    300.00|          |    0.001|      0.1|FALSE    |     0.04|FALSE    | #> |BSEP        |     12.80|          |    0.013|      0.1|FALSE    |     0.02|FALSE    | #> |OCT2        |     67.00|study 006 |    0.002|      0.1|FALSE    |     0.02|FALSE    | #> |MATE1       |      3.60|study 006 |    0.046|      0.1|FALSE    |     0.02|TRUE     | #> |MATE2k      |      1.10|study 006 |    0.150|      0.1|TRUE     |     0.02|TRUE     |"},{"path":"/reference/transporter_reference_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Drug transporter reference data — transporter_reference_data","title":"Drug transporter reference data — transporter_reference_data","text":"Drug transporter reference data","code":""},{"path":"/reference/transporter_reference_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Drug transporter reference data — transporter_reference_data","text":"","code":"transporter_reference_data"},{"path":"/reference/transporter_reference_data.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Drug transporter reference data — transporter_reference_data","text":"'transporter' name drug transporter protein. 'fda_thld' threshold relevant interactions defined FDA guidance. 'ema_thld' threshold relevant interactions defined EMA guidance. '' perpetrator concentration applicable interaction.","code":""},{"path":"/reference/transporter_reference_data.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Drug transporter reference data — transporter_reference_data","text":"FDA guideline: Vitro Drug Interaction Studies — Cytochrome P450 Enzyme- Transporter-Mediated Drug Interactions, 2020. EMA Guideline investigation drug interactions, 2012","code":""},{"path":"/reference/transporter_reference_data.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Drug transporter reference data — transporter_reference_data","text":"","code":"transporter   fda_thld   ema_thld    i \"Pgp_int\",    10.0,      10.00,     \"igut\", \"Pgp_sys\",    0.1,       0.02,      \"imaxssu\", \"BCRP_int\",   10.0,      10.00,     \"igut\", \"BCRP_sys\",   0.1,       0.02,      \"imaxssu\", \"OCT1\",       NA,        0.04,      \"imaxinletu\", \"OATP1B1\",    0.1,       0.04,      \"imaxinletu\", \"OATP1B3\",    0.1,       0.04,      \"imaxinletu\", \"OAT1\",       0.1,       0.04,      \"imaxssu\", \"OAT3\",       0.1,       0.04,      \"imaxssu\", \"BSEP\",       0.1,       0.02,      \"imaxssu\", \"OCT2\",       0.1,       0.02,      \"imaxssu\", \"MATE1\",      0.1,       0.02,      \"imaxssu\", \"MATE2k\",     0.1,       0.02,      \"imaxssu\""},{"path":[]}]
